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ABSTRACT 
 
There are multiple risk factors which contribute to cutaneous melanoma, including but not 
limited to, ultraviolet (UV) radiation exposure, the amount of freckling, skin and hair colour, 
skin phototype, and personal and familial melanoma history. One of the single strongest risk 
factors for cutaneous melanoma is a high naevus count. In the clinical setting, thorough total 
body examinations are hindered by the practical limitations of counting high numbers of 
naevi. To overcome this problem, multiple prediction models which estimate naevus count 
and cutaneous melanoma risk have been proposed. However, the progression and 
standardisation of these models has been hampered by the lack of independent validation, 
variation in methods and incorporated variables, and the absence of consensus as to what 
constitutes ‘at risk’. Consequently, rapidly and accurately identifying these ‘at risk’ 
individuals in the clinical setting remains difficult. Individuals with multiple naevi with distinct 
naevus distribution patterns have been observed clinically. The concept of naevus 
distribution pattern has not been thoroughly described in the literature nor have these 
‘patterns’ been formally characterised. Through this study, we aim to determine if clinically 
distinct naevus distribution patterns, in at risk individuals, can be recognised, characterised 
and classified. Furthermore, whether a stratification model can be developed for the future 
classification of individuals based on naevus distribution pattern. 
 
2D and 3D whole body images were captured from 1225 high risk individuals (with personal 
and/or familial melanoma history) selected from the Brisbane Naevus Morphology Study 
(BNMS) using the FotoFinder imaging system (FotoFinder Systems GmbH, Germany) or 
the Vectra WB360 imaging system (Canfield Scientific Inc, USA). To ensure the accurate 
identification of true naevi, only naevi ≥ 5 mm were included in naevus counts. Naevi ≥ 5 
mm were counted on the head and neck, back, chest and abdomen, upper limbs and lower 
limbs. Naevus distribution clusters were derived using mclust and k–means cluster analysis 
based on anatomical regional naevus counts ≥ 5 mm. Naevus counts were adjusted for both 
age and sex. Individual pigmentation phenotypes and genotypes were also assessed. 
 
Three distinct clusters of naevus distribution pattern were identified using mclust analysis in 
the BNMS population. Cluster 1 (N=427) contained participants with a high total body 
naevus count (mean 49 ± 34 naevi ≥ 5 mm) with naevi predominantly centralised to the trunk 
and either the upper or lower limbs. Cluster 2 (N=552) constituted participants with a lower 
total body naevus count (mean 10 ± 6 naevi ≥ 5 mm) and lower relative naevus counts at 
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each anatomical site in comparison to Cluster 1. Naevi in this cluster were more likely to be 
located to the trunk (back, chest and abdomen) and extremities. Cluster 3 (N=247) contained 
participants with the lowest naevus counts (4 ± 5 naevi ≥ 5 mm) from all three groups. In this 
cluster the rare naevi present were more likely to be located to the back. We have also 
proposed an early classification model that would enable a rapid assessment of an individual 
in the clinical setting, by simply performing visual overview of the number of naevi and 
pattern of naevus distribution across each anatomical site to stratify the patient into a given 
cluster.  
 
In order to further characterise these naevus distribution patterns defined within each 
cluster, known phenotypic and genotypic melanoma risk factors were also investigated in 
this population. Hair and eye colour, as well as the number of naevi were positively 
associated with cluster.  Specifically, individuals in Cluster 1 were more likely to have light 
or red coloured hair and were less likely to have dark coloured eyes, compared to the other 
two cohorts. Cluster 3 contained a higher proportion of dark haired and dark eye coloured 
individuals. Correlation to naevus distribution clusters was also observed with some SNPs 
in pigmentation genes which have been associated with naevus count/ or pigmentation. An 
example of some of these genes include MC1R, MTAP, OCA2, MITF and PLA2G6. 
Consistently, SNPs in pigmentation genes previously associated with naevus count and/or 
pigmentation i.e. MC1R, MTAP, OCA2, MITF and PLA2G6 showed correlation to naevus 
distribution clusters.  
  
A method which classifies individuals into distinct clinical groups based on pattern of naevus 
distribution across anatomical sites may offer an alternate method for clinicians for rapid 
assessment, stratification and identification of individuals at risk in the clinical setting. Here 
we have described three distinct clusters on the basis of pattern of naevus distribution and 
proposed a novel, rapid, stepwise early classification model for easy clinical assessment by 
doctors of all levels of expertise.  This suggests that such clustering analysis, while on the 
basis of naevus count and distribution, may also be a proxy for additional risk factors. Future 
research will aim to replicate and validate these findings in diverse populations to confirm 
these distinctive groups.  
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
 
Melanin is a complex biopolymer which is produced from the oxidisation and polymerisation 
of tyrosine [1]. Following synthesisation in epidermal melanocytes, it is transferred to 
keratinocytes were it is present in a range of colours (e.g. pheomelanin, eumelanin) in the 
hair, skin, and iris of the eye [2] and serves a primary role in protection against ultra violet 
radiation [3]. Melanocytic naevi are benign proliferations of naevus cells, a subtype of 
melanocytes.  Naevi are formed when aggregates of naevus cells come together in groups. 
The number of acquired melanocytic naevi is one of the strongest predictors of cutaneous 
melanoma risk. With cutaneous melanoma (hereafter referred to as melanoma) rates 
continuing to rise, it is crucial to consider the factors and mechanisms which are driving 
these processes, and using this information when investigating patterns of naevus 
distribution across the body. Naevi are a known precursor to melanoma, and a high total 
naevus count is one of the single strongest predictors of melanoma risk. Naevus count is 
defined as the number or frequency of naevi located at a specific anatomical site or over the 
entire body [4] .     
 
1.1 The risk factors of melanoma 
An individual’s melanoma risk is largely attributable to environmental factors, phenotype, 
genotype and previous melanoma history.  
 
1.1.1 Environmental factors 
Ultraviolet radiation (UV) is the primary etiological environmental factor which is known to 
directly contribute to melanoma risk [5]. Prolonged or intermittent exposure of UVA and UVB 
from sunlight or artificial tanning devices are known to cause sunburn and promote 
melanoma development through inducing DNA damage and mutational changes (known as 
UV signature mutations) that affects DNA repair mechanisms [6]. Intermittent sun exposure 
has also been associated with a higher melanoma incidence rate as compared to prolonged 
sun exposure [7]. Two UV-dependent development pathways to melanoma have been 
proposed in the literature; one hypothesised pathway is that intermittent sun exposure 
produces changes in naevi biology, inducing melanoma onset within a naevus. In contrast, 
when sun exposure is prolonged, lentigo maligna, an atypical pigmented macular lesion 
often found on severely sun-damaged skin, is more likely to develop [8] .  
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UV exposure in childhood is also thought to contribute significantly to melanoma 
development in later life  [9]. Studies have reported that an increased UV exposure in 
childhood (before age 10) was associated with an increased risk of melanoma occurrence 
and decreased survival, due to an increased mutational burden in these tumours [10, 11]. 
Latitude gradient has also been demonstrated to influence melanoma risk. Multiple studies 
have demonstrated the correlation between higher melanoma incidence and mortality and 
lower latitude geographical regions, such as Australia, New Zealand and South Africa [12, 
13].  Sunlight exposure is also known to stimulate the naevogenesis process. As such, 
increased sun exposure is closely associated with an increased naevus count, one of the 
most significant melanoma risk factors [14]. 
 
1.1.2 Heredity and genetics 
It is well known that melanoma commonly clusters in families [15]. Meta-analyses have 
shown that individuals with a first degree relative affected by melanoma had an 
approximately two-fold increased risk of melanoma [15, 16]. This heightened risk may be 
attributable to a shared environment and/or shared genetic risk [17], with twin studies 
demonstrating that the heritability of melanoma is 55% [18].   
 
One percent of melanoma occurs in individuals with a strong family history [19, 20] . Studies 
of large families in which melanoma is dominantly inherited have identified nine high 
penetrance genes including CDKN2A, CDK4, BAP1, POLE, TERT, POT1, TERF2IP, ACD 
and the CXC locus ( as reviewed in Potrony et al) [21]. Mutations in CDKN2A are much 
more common than other causal genes. Gene screening in 2,511 melanoma-prone families 
found CDKN2A mutations in 19% of cases and mutations in the remaining seven genes 
combined (CDK4, CXC, BAP1, TERT, POT1, TERF2IP and ACD) were only identified in an 
additional 3% [21]. 
 
The role of genetics in melanoma predisposition in the general population has been explored 
in large genome-wide association studies (GWAS). This research found that some high 
penetrant loci were also associated with risk in the general population e.g. CDKN2A and 
TERT. However, additional loci reach statistical significance on a population level including 
ARNT, PARP1, CYP1B1, CASP8, SLC45A2, CDKAL1, ARG3, RAD23B, CCND1, OBFC1, 
TYR, ATM, OCA2, FTO, MC1R, ASIP, MX2, PLA2G6, PPARGC1B, AGR3, FAM208B, 
TPCN2, TTC7B and PIGU [22] [23]. Large cohort studies show that nevus genes identified 
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by GWAS all influenced melanoma risk, but the reverse was not found in that not all risk loci 
for melanoma influenced naevi on a population level [22].  
 
1.1.3 Previous history of melanoma 
Melanoma patients have an elevated risk of subsequent melanoma occurrence in the future 
[24]. The risk of a second primary melanoma was highest, approximately 0.5% per year for 
the first five years of follow-up [24]. Incidence rate of second primary melanoma occurrence 
was highest in men (357 / 100,000) compared to women (297 / 100,000) [24]. Risk of 
developing a second primary melanoma was reported to be greatest in individuals aged 30–
34 and 65–69 years, suggesting different causes of secondary primary melanomas in these 
age groups [24].  In general, second primary melanomas were thinner and non invasive (in 
situ) [25]. This is likely due to increased monitoring by doctors and increased patient 
education, giving them better awareness of clinical characteristics and changes in their skin 
[26].  
 
1.1.4 Pigmentation 
Individual pigmentation characteristics such as hair eye and skin colour have all been 
associated with melanoma risk [27, 28]. Light hair colours (blonde, light brown, red hair 
colour) reported in European-background populations, have been associated with higher 
melanoma risk [27, 29]. As hair colour is determined by genetic variants, it is unsurprising 
that the ‘red hair gene’ MC1R is a risk factor for melanoma risk [30]. This is discussed further 
in section 1.2.5.1.  
 
Eye colour is also a commonly-considered melanoma risk factor, and has significant 
variation European-ancestry individuals [31]. Blue eyed individuals are reported to have an 
increased melanoma risk, 1.55 (95% confidence interval (CI) 1.35, 1.78) times greater than 
brown eyed individuals [32]. From a comprehensive meta-analysis, Gandini et al concluded 
that having blue, green or grey eyes also correlated with increased melanoma risk 
(RR = 1.62; 95% CI: 1.44 -1.81) [27]. Blue eye colour was more frequently associated with 
fair hair and skin colours, while brown eyes were commonly observed with darker brown 
hair colour and olive and darker skin colours [33, 34], demonstrating the overlapping 
features of these phenotypes as well as the interaction of pigmentation genotypes. 
 
The incidence of cutaneous melanoma has continued to increase in fair skinned populations 
globally [35, 36]. Individuals with fair skin and a poor tanning ability are also known to be 
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much more susceptible to melanoma development [5] compared to darker skinned 
individuals or those of non-European descent [37]. This is due to the increase presence of 
epidermal eumelanin, which is deposited in large non-aggregated melanosomes throughout 
the epidermis in darker skinned individuals, or those with an ability to tan. In fairer skinned 
individuals with reduced tanning ability, these aggregates are smaller and restricted to the 
skin basal layers [38, 39]. Skin colour and tolerance of UV exposure is influenced by genetic 
factors. The most commonly implicated genes in skin colour and freckling in fair-skinned 
populations are TYR, MC1R and SLC24A4 [38].  
 
1.1.5 Age and sex 
Age and sex are significant independent risk factors when considering cutaneous melanoma 
incidence [40]. When considering a younger age demographic ≤ 40 years, adolescents and 
young women are at an increased risk compared to men [41, 42]. This was thought to be 
due to increased intermittent sun exposure in youth, as well as the use of artificial tanning 
devices [43, 44]. However, in ages > 40 years, the incidence rate reverses, and melanoma 
incidence in men increases, potentially drive by androgen depletion [41, 42, 45]. While 
recent studies showed there was a plateau in incidence rates in younger persons, the rate 
of  melanoma incidence and mortality continues to be significantly higher in older age groups 
( > 60 years) [40, 46, 47].  
 
Overall, older males have been reported to have a poorer prognostic outcome, and are more 
likely to have thicker tumours (> 2 mm) at time of diagnosis [40]. Middle aged and older men 
are reported to suffer a disproportionately higher mortality rate from melanoma compared to 
women [48]. Age contributes to increased melanoma risk. For example, a 70 year old 
Australian male has a 2.5% risk of melanoma development in the next ten years, a risk eight 
times higher than that of a 30 year old man. A 70 year old woman has a 1% risk of melanoma 
development over a 10-year period, which is three times higher than that of a 30 year old 
woman [49]. This increase in risk with age is most likely attributed to more time spent 
outdoors in retirement, increased likeliness of repeated prolonged sun exposure over 
lifetime and an age-related decrease in immune response [50].   
 
1.1.6 Naevi as a risk factor for melanoma 
Melanoma risk increases with naevus count [51]. The total number of acquired melanocytic 
naevi is the most significant risk factor when considering cutaneous melanoma [51-56]. 
Meta-analysis studies have concluded that individuals with a high naevus count (> 100 
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naevi) have a seven-fold increased risk (pooled RR = 6.89; 95% CI: 4.63, 10.25), compared 
to individuals with a low naevus count (< 15 naevi) [57]. The same study concluded that 
melanoma risk was significant even for individuals with a medium-low naevus count of “16–
40” naevi on the whole body compared to a total count of “0–15” naevi (pooled RR = 1.47; 
95% CI: 1.36, 1.59) [57]. The presence of atypical naevi (> 5 atypical naevi) was also 
associated with increased risk, six times that of individuals with no atypical naevi [57]. 
Naevus size is also significant, with naevi > 5 mm in size (atypical naevi) more likely to 
undergo malignant transformation due to genetically influenced changes [58]. In population 
studies carried out in adults, the anatomical distribution of naevi described to date has been 
predominantly focused on the back, arms and legs. This is largely due to these sites 
receiving the greatest level of intermittent sun exposure over the course of time and have 
also been shown to be common sites for melanoma [59-62]. 
 
While increased naevus count is strongly associated with an increased melanoma risk, 
individuals with low naevus counts are still susceptible to melanoma development through 
other risk phenotypes [37]. This concept is explained through the divergent pathway to 
melanoma hypothesis: some individuals have a greater proliferation propensity for naevus 
development following modest intermitted sun exposure, while others have a lower naevus 
proliferation capacity and require prolonged sun exposure [8]. This pathway is also 
supported by opposing melanoma risk phenotypes, where individuals have either many 
naevi and darker pigmentation features, or few naevi and lighter pigmentation features [63].  
 
The risk of developing naevi is, in turn, modulated by environmental, phenotypic and genetic 
factors. The presence of naevi is a phenotypic trait under strong genetic control [64]. 
Epidemiology studies have suggested that there is a complex association between naevus 
density1, specific pigmentary traits and sunburn history [65, 66]. It has been well established 
that high sun exposure and sun burns in childhood results in higher naevus counts in 
childhood [10, 67, 68]. Furthermore, there is an interactive effect between naevi and other 
risk factors. In a Norwegian-Swedish population of women, hair colour and naevi were 
shown to be associated with melanoma risk. In women with more than two large asymmetric 
                                            
 
 
1 Naevus density: the naevus count divided by the surface area of each anatomical site. Proportional body 
surface area estimates can also be used to account for changes in relative surface area for each anatomical 
site. It can also be calculated as naevus count per square meter of body surface area (calculated with 
Mosterllar formula) [53, 63].  
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naevi, melanoma risk was greatest in women with blonde or red hair, who have a two-fold 
and four-fold risk compared to women with black or brown hair [69], suggestive of genetic 
interactions between pigmentation, MC1R and melanoma. 
 
In conclusion, there are multiple recognized risk factors for melanoma. Ideally, a holistic 
algorithm would be capable of weighing each of these risk factors and generating a risk 
score for each individual, to inform decisions regarding surveillance intensity and frequency. 
Currently, there are a number of risk prediction models and algorithms, discussed in Section 
1.2.6.  
 
1.2. Naevi  
Both naevi and melanoma arise from melanocytes; therefore, it has been suggested that 
naevi are markers of inherent melanocytic proliferation potential and an increased 
susceptibility to melanoma development [70]. As a result of this, the number, size and 
anatomical location of naevi have been investigated in multiple studies due to their well 
described epidemiological association with melanoma risk [51, 57, 62, 71]. As mentioned 
previously, naevi have been conclusively shown to be associated with melanoma risk [51-
56]. Furthermore, naevi number and size also modulate melanoma risk [57, 72]. What is 
less clear is whether the anatomical distribution of naevi affects melanoma risk beyond 
naevus size and number.  
 
1.2.1 Anatomical distribution of naevi 
Anatomical distribution of acquired melanocytic naevi and naevus count have been widely 
discussed in children, adolescent and adult populations. These studies have notably 
focused on the number and size of naevi present at each individual body site [73-77]. Studies 
also frequently investigate the correlation between sun exposure, sunburn history and 
melanoma incidence to anatomical location and naevus count in both youth and adult 
populations [62, 70, 73, 77-80]. However, to the best of my knowledge, none of these studies 
have assessed whether there is a clinically-definable pattern to naevus distribution.  
 
The anatomical distribution of acquired melanocytic naevi (AMN) has been under close 
scrutiny by researchers [53, 78]. This interest has been primarily driven by the relationship 
between the number of naevi across different anatomical sites and melanoma incidence and 
aetiology [78]. In white population studies, different distribution patterns of naevi have been 
observed, which seem to be influenced by both sex and sun behaviour practices [61, 81, 
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82]. In males, a greater naevus distribution on the trunk is frequently observed, while in 
females, the limbs are reported to have a higher naevus distribution [81].  
 
The anatomical distribution of AMN in children has been thoroughly investigated [52, 53, 66, 
76, 78, 80, 83]. It is thought that understanding site specific evolution of naevi at an early 
age may aid in explaining the differences in melanoma aetiology and incidence at different 
anatomical sites in adult life [78]. The effect of sex on distribution of naevi was assessed in 
5 to 7 year old European children by Autier et al. The total naevus count for naevi > 2 mm 
was higher in boys than in girls; in boys, the number of naevi was higher on the trunk, 
shoulders, head and neck [52]. Girls were more likely to have higher naevus counts on the 
upper and lower limbs. Smaller naevi (2 – 4mm) were more frequently concentrated to the 
lateral aspects of the arms while large naevi (≥ 5 mm) were more common on the posterior 
trunk [52]. Similar anatomical distribution trends were also reported in similarly-aged 
Australian children [76, 78, 83]. However, Australian children had slightly higher naevus 
counts, which may be explained by geographical latitude, and there were equal distribution 
of naevi on the upper limbs between sexs [76]. In a study of Lithuanian children, naevus 
density for naevi > 2 mm was assessed. In contrast to previous studies, boys were reported 
to have higher naevus densities at all sites compared to girls [80]. The face and neck were 
reported to have the highest naevi density in proportion to body site regardless of sex, age 
group and geographical location [53, 78-80, 84]. 
 
In adults, similar naevus anatomical distribution trends were reported for men and women 
[54, 81].  In an Australian population, higher naevus counts were reported for the arms and 
legs in women, while men showed higher naevus counts on the back, head and neck [14]. 
These findings were also observed in adult Spanish, Swedish and Scottish populations [54, 
85, 86]. Interestingly, the sex differences in naevus anatomical location were similar to the 
distribution of melanoma in men and women. Grulich et al reported the most common site 
for melanoma in males was the back, head and neck, while in females, the most common 
site was the legs and upper arm [14]. This poses a very strong correlation between the 
presence of naevi and melanoma incidence [87].  
 
Anatomical distribution of naevi can be indicative of the level of sun exposure received and 
melanocyte density at a particular anatomical site [8, 88]. However, since the back, which 
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generally receives less sun exposure, also has a high density of naevi, it has been proposed 
that there is also a site-dependent inherent proliferative potential of melanocytes, and thus 
a site-dependent susceptibility for melanocytes to undergo malignant transformation [8, 88]. 
In studies assessing melanocyte density across anatomical sites, the highest densities were 
observed at the back and shoulders (mean 1.17, 95% CI0.88–1.15), followed by the upper 
(mean 0.52, 95% CI 0.33–0.72) and lower limbs mean (0.61, 95% CI 0.45–0.77). The lowest 
melanocyte density was on the anterior trunk [88].    
 
1.2.2 Naevus counts in specific anatomical sites as a proxy for total naevus count  
Given the impracticality of conducting full body naevus counts (due to time and cost 
restrictions), the number of naevi at various anatomical locations have also been studied in 
an effort to establish the correlation between naevi number at a specific anatomical site and 
total body naevus count. Studies have achieved this by assessing the relationship between 
total naevus count to naevi number at specific anatomical sites, and proposed cut off or 
threshold values with which to determine total naevus count and predict melanoma risk [54].   
 
Naevus site count association study results have varied, but appear to be affected by subject 
age and sex. In adults, the upper arm, legs and trunk were identified most frequently for their 
high correlation to total naevus count [54, 85, 86, 89]. The arm naevus count has one of the 
highest correlation scores to total naevus count (TNC) [54, 55, 62, 90]. However, this is not 
consistent for men and women.  Farina-Alvarez et al reported that the arm was the best 
predictor site in men, but the thigh had a higher correlation to TNC in women [89]. This 
finding was also supported in a small Swedish study [86]. In contrast, a U.K. based female 
twin study, showed that TNC ≥ 2 mm was more strongly correlated with the arm naevus 
count than any other body site. This same finding was then reproduced in a replication cohort 
of UK men and women [91].  The right upper arm is frequently identified as having a slightly 
higher correlation score to TNC than the left arm [91]. Behaviour patterns including clothing 
selection could also influence the presence of naevi at this site due to prolonged, intermittent 
sun exposure [86].   
 
The legs were deemed the second best site to predict TNC following the right and left arms 
in four separate studies [54, 62, 85, 86, 89, 91]. In general, it was reported that women 
tended to have higher naevus counts, for naevi ≥ 2 mm, on the lower limbs than men [54, 
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62]. This higher naevus count at this site was reflected in some studies, with a higher 
correlation score for the leg than other sites [54, 85, 86, 92].  
 
The back and trunk also produced significant correlations to total naevus count [85]. 
Although naevus counts were generally higher at this site in relation to other anatomical 
sites, potentially due to the higher surface area, this did not consistently correlate with the 
trunk being an accurate predictor site for TNC overall. In general, naevus counts tend to be 
highest on the trunk compared to other anatomical regions and higher in men than women 
[54, 62, 70].  In a study of Spanish adults, the back and anterior trunk reported the strongest 
correlation to TNC after the arms, in both men and women (correlation 0.85 and 0.75 in both 
sexes) [89]. The same finding was also reported in a Scottish population, where a high 
correlation for the back was seen in both sexes [85].   
 
As the right arm has been most frequently reported to correlate well with TNC in both sexes, 
researchers are looking to establish naevus count thresholds and new strategies to 
incorporate this site to screen individuals [4, 54, 90, 93]. The ‘20 naevi on the arm rule’ was 
proposed by Quéreux et al in 2006 and was developed to define melanoma risk [90, 93]. 
This rule was assessed in 2175 patients in a multicentre study across Italy, Germany, 
Greece and Serbia and was proven to be an accurate predictor of TNC in individuals <50 
years of age [90]. Echeverria et al also proposed a statistically validated naevus count 
threshold for the arm in a study of 292 patients. They estimated cut off values of 25, 50 and 
100 to estimate various levels of TNC and associated level of patient risk. They concluded 
that the presence of more than 5 naevi on the arm best predicted patients with a TNC greater 
than 50 [54]. In contrast, Argenziano et al reported that having more than 20 naevi on the 
arm correlated to a TNC >50 [90].  
 
While many studies have undertaken different approaches to determine total naevus count 
by considering different anatomical sites, an accurate, reproducible and standardised 
method has not yet transferred to clinical practice. Overall, studies were often limited due to 
potential study bias. Differences in counting methods was a significant source of bias, and 
also made direct comparisons between studies challenging. The experience of people 
conducting naevus counts was also a source of bias, and limited the accuracy and 
reproducibility of these study findings in other populations, as researchers’ ability to 
accurately identify true naevi was unclear. Inconsistencies in the size of naevi included was 
also identified as a source of bias. While some studies counted naevi from ≥ 2 mm, others 
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counted naevi ≥ 5 mm. Again, this made direct comparison of results between studies 
challenging and difficult to translate to clinical application in a standardised manner.  Study 
participant selection and study population were also potential limiting factors to study 
outcomes. Differences in population age was also variable. This influenced threshold or cut 
off scores to determine TNC.  Geographical location and UV exposure, sex, and sourcing of 
participants also hindered the ability to reasonably compare study outcomes. 
 
As melanoma incidence continues to increase in fair-skinned populations [93, 94], it would 
be useful to have a simple and practical tool, applicable in routine clinical practice, to stratify 
patients at higher risk of melanoma. Although, the upper arm correlates well with TNC in 
both sexes, the reliability and reproducibility of the method has not been fully validated in 
diverse populations. Hence, it has yet to be adopted into clinical guidelines. The clinical 
characterisation and classification of naevus distribution patterns could prove a constructive 
tool to aid in the identification and clinical management of individuals for closer surveillance, 
simply by an overview assessment of the patient at the time of the first clinical skin 
examination. Consideration of naevus distribution pattern may also potentially add to known 
correlations between naevus number at an anatomical site and site specific melanoma risk 
[95-97]. Given that prior studies have not assessed or clinically characterised the patterns 
of naevus distribution, this Thesis aims to fill this knowledge gap and to understand if there 
are clinically distinctive distribution patterns for naevi ≥ 5 mm in an adult population of 
European ancestry, and explores the potential of using this information to create a 
stratification tool for clinical use.  
 
1.3 Genetic variants associated with naevus count and phenotypic features  
Melanoma aetiology is multifactorial. The presence of a high number of acquired 
melanocytic naevi is one the strongest visual phenotypic risk factors for melanoma [37, 83]. 
Host factors including hair, eye and skin pigmentation, genotype, UV exposure and tanning 
response have also been thoroughly investigated regarding their influence as melanoma 
risk factors [30, 98, 99]. Total naevus count and pigmentation traits are highly heritable [31, 
64, 100]. These characteristics are tightly regulated by multiple genes, most of which are 
implicated in pigmentation. Pigmentation genes regulate expression of phenotypic 
characteristics by controlling melanin production. This includes the rate at which melanin is 
synthesised, its chemical components, its assembly and the locations at which it is deposited 
[2]. Genetic polymorphisms within key pigmentation genes have been shown to be 
significantly associated with naevus counts in large GWAS studies. These include MC1R, 
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IRF4, TYR, MTAP and PLA2G6 (as reviewed in Duffy et al 2018) [22]. An additional gene 
associated with naevus count and melanoma risk is MITF [101]. Known risk genotypes in all 
of these genes are reviewed below and evaluated in this Thesis. Of note, not all of the SNPs 
selected here are proven to moderate the protein expression of respective gene. However, 
given the credibility of each gene as a candidate means that they are consistently assigned 
to those proximal genes in the literature. Therefore, for the purposes of this thesis these 
SNPs will henceforth be referred according to their assigned genes in the literature. 
Throughout the text, the P value of selected SNPs has been reported from GWAS studies. 
The P value indicates the likelihood that the frequency of that SNP differs in the disease 
population as compared to an unaffected population [102]. Given that hundreds of 
thousands of loci are being tested simultaneously in a GWAS the traditional level of 
significance (p=0.05) is divided by the number of SNPs in the array. This is known as the 
Bonferroni correction [103]. Using this methodology, we can determine the probability that 
variant is associated with the disease due to random chance. The minimum P value 
threshold for significance for GWAS studies is P ≤ 5x10-8 [103].  
 
1.3.1 MC1R 
Among the pigmentation genes investigated, melanocortin-1 receptor (MC1R) is one of the 
most well-described. MC1R is located on chromosome 16q24.3 and strongly affects hair 
and skin colour, sun sensitivity and freckling. It is also associated with an increased risk of 
melanoma [104, 105]. There are over 85 variants of MC1R found in approximately 70% of 
the European population [37]. Nine of these variants, called “R” and “r” variants, play a role 
in determining red hair colour to some degree. The ‘R’ variants (Asp84Glu, Arg142His, 
Arg151Cys, Arg160Trp, Asp294His) are more strongly associated with red hair colour (RHC) 
than the ‘r’ variants (Val60Leu, Val92Met, Iso115Thr, Arg163Gln) [106, 107]. The ‘R’ 
variants are also associated with a higher incidence of freckling, higher probability of fair 
skin and increased propensity to burn [105, 106]. MC1R genotypes have been reported to 
be associated with naevus count in both adults [22, 108] and children [104]. Although MC1R 
is a significant risk factor for melanoma risk, it does not reach GWAS significance for naevi 
[22]. This may be attributable to the fact that the relationship between MC1R genotype and 
naevus count is complex and may be modulated by variants in other pigmentation genes, 
such as OCA2 and MITF [33, 104, 109].  
 
Large studies have demonstrated that MC1R genotypes are associated with melanoma risk. 
Heterozygous carriers of the ‘R’ variant have a two-fold increased melanoma risk and 
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homozygotes (RR) have a four-fold increased melanoma risk, compared to WT individuals 
[22, 30, 110, 111]. This increased risk may not be attributable to MC1R’s role in pigmentation 
alone, but rather reflect MC1R’s response to DNA damage in human melanocytes, as 
research has shown that MC1R plays a key role in the prevention of photo-carcinogenesis 
[105, 106].    
 
1.3.2 IRF4 
The interferon regulatory factor 4 (IRF4) located at chromosome 6p25.3, is a member of the 
interferon regulatory factor family of transcription factors which respond to interferon and 
cytokine stimulants by regulating gene expression [112]. A GWAS meta-analysis involving 
52,506 individuals found one SNP (rs12203592*C/T) to be highly associated with naevus 
count (P=4×10−37) [22]. There is an inverse association between alleles when comparing 
naevus count in adolescents and adults [112], suggestive of a gene-by-age interaction. 
Specifically, the C allele is associated with a higher naevus count in adults while the T allele 
is associated with high naevus counts in adolescents [112]. The alternate, or minor, T allele 
of IRF4 [113] has also been shown to be significantly associated with pale skin complexion 
(P=6.2x10-14), light eye colour (P=6.1x10-13), dark hair colour (P=7.1x10-13) and poor tanning 
response (P=3.9x10-89) [30, 113].  
 
The IRF4 gene is associated with melanoma risk and this is thought to be attributable to its 
role in encoding the B-cell protein responsible for cell proliferation and differentiation [113] 
and its subsequent expression in melanocytic lesions [30]. The role of the rs12203592 in 
melanoma age of onset was evaluated 2,013 adults with a diagnosis of melanoma. This 
revealed that, similar to the age related associations in naevus count, the C and T genotypes 
had opposite associations in different aged cohorts. The authors postulated that this SNP 
could modulate the bimodal age distribution of melanoma [114]. Consequently, this SNP did 
not reach genome wide significance on a population level which the authors speculated was 
due to the conflicting risk associations depending on age [22, 112].  Research on this SNP 
has shown that it is in the regulatory region of the IRF4 gene and interacts with the promoter 
through chromatin looping. This affects allele-specific transcription of IRF4 which the authors 
was an example of a non-coding SNP which modulated skin colour through transcriptional 
regulation [115].   
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1.3.3 MTAP 
Methylthioadenosine phosphorylase and Patatin-like phospholipase domain-containing 
protein 9 (MTAP) is located at chromosome 9p21.3 and encodes an enzyme which 
catalyses the phosphorylation of methylthioadensose (MTA). MTAP is a pigmentation gene 
which is also regulated by MITF. In a GWAS study of 10,000 individuals of European 
descent, MTAP SNP rs28777 was identified to be associated with hair colour (P=8.9x10-14), 
skin colour (P=9.5x10-4) and tanning ability (P=2.2x10-10) [113]. Additional SNPs 
rs16891982, rs26722 and rs13289*C/G were also associated with hair and skin 
pigmentation and tanning ability [113]. MTAP is often co-deleted with adjacent melanoma 
gene CDKN2A, however MTAP is also thought to be a tumour suppressor gene in its own 
right [30].   
 
One SNP in MTAP was strongly associated with total naevus count and number of large 
naevi in a large GWAS study of Caucasian populations; rs7023329 (P=2.12x10−37) [22]. An 
earlier twin study also found an association between naevus count and another MTAP SNP, 
rs4636294 (P=3.4x10−15) [116]. Genotyping data from a case-control study from 2,497 
individuals also identified MTAP SNP rs10757257 to be associated with naevus number 
[117]. Whether MTAP increases or decreases naevus count is still undecided. SNP 
rs7023329 was associated with a lower naevus count in a UK based population [117], while 
in a US population, rs7023329 was associated with an increased naevus count [118]. While 
this variation in interaction between MTAP SNPs and naevus count has not been well 
described, differences in interactions between sun exposure and genotypes may contribute 
to this variability [117].  
MTAP SNP rs7023329 (P=4.03×10−7) has also been associated with melanoma risk in a 
GWAS study in Australian and European populations, due to an association with tumour 
progression generally [119, 120]. Cells deficient in MTAP activity result in higher 
accumulated levels of MTA, which supports tumour progression. Increased secretion of MTA 
is thought to result in increasing invasive potential, vasculogenesis and inhibition of protein 
argenine methyltransferases (PRMTs), while also influencing surrounding cells’ signalling 
and proliferation [120, 121]. Additional SNPs associated with melanoma risk included 
rs10757257 (P=3.4x10-8) in 3,131 melanoma cases from two independent studies [116, 
122]. An association between MTAP rs7023329 and number of naevi has also been 
confirmed in a recent familial case-control study of melanoma [118].  
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1.3.4 PLA2G6 
Phospholipse A2, group VI (PLA2G6) found at chromosome position 22q13.1 belongs to the 
phospholipase A2 superfamily of genes, located at chromosome 22q13 [116]. A GWAS 
study utilised 297,000 SNPs in 1,524 twins in the UK to identify loci which contributed to 
naevus count. One of the most significant associated SNPs identified was rs2284063 in 
PLA2G6 (P=2.3 × 10-6) [116]. A subsequent case-control study found that this SNP was 
associated with an increased total naevus count and an increased number of larger naevi 
[117]. This relationship was highly significant in further a meta-analysis (P=3×10−18) [22, 
116, 117]. An alternate SNP, rs132985, was also associated with naevus count in a twin 
cohort (P=1x10-6). 
 
PLA2G6 genes are responsible for encoding esterases which cleave glycerophospholipids. 
These enzymes maintain the phospholipid membrane of cells, and are also linked to cell 
growth, proliferation and apoptosis in various cancer cell types [116]. It is therefore 
hypothesised that PLA2G6 may play a similar role in melanoma progression. PLA2G6 SNPs 
rs132985 (P=2.6x10-7) and rs2284063 (P=2.40×10-9) have also been associated with 
melanoma risk in 3,131 melanoma cases from the UK and Australia [116, 117]. This 
contrasts with findings from Kvaskoff et al, which found that neither variant were associated 
with melanoma risk in a case-control study population of melanoma patients from the 
Queensland study of Melanoma: Environmental and Genetic Associations (Q-MEGA), with 
controls from the Brisbane Twin Naevus Study (BTNS) [122]. The relationship between the 
genotype of a single SNP and both naevi and melanoma risk may be more complex for 
PLA2G6, as the rs2284063 SNP contributes to an extended haplotype thought to contribute 
to increased naevus count and melanoma risk [30, 116, 117]. 
 
1.3.5 CDKN2A 
Cyclin-dependent kinase Inhibitor 2A (CDKN2A) located at chromosome 9p21.3, was 
initially identified as an autosomal dominant melanoma gene in rare familial melanoma 
cases. Mutations within the gene are highly penetrant and confer a high lifetime risk of 
developing melanoma [123, 124]. Years later, GWAS studies in the general population 
identified that common SNPs within and surrounding CDKN2A gene were associated with 
an increased risk of melanoma [22]. CDKN2A is physically adjacent to MTAP, however the 
relative contribution of germ line polymorphism in each locus has been controversial (MTAP 
regulatory polymorphism discussed in 1.3.3). However it is clear that protein coding mutation 
status of CDKN2A is associated with naevus phenotypes [125]. CDKN2A variants do not 
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have any consistently described pigmentary phenotypes in terms of hair, skin or eye colour 
[126]. Furthermore, CDKN2A is not an independent risk locus for naevus count in large 
population studies [22]. However, CDK2NA is adjacent to MTAP, which is highly associated 
with naevus count in GWAS analyses. In addition, pathogenic mutations in CDKN2A are 
associated with increased naevus counts in families with melanoma. Therefore, variants in 
coding and noncoding regions of this gene may contribute to moliness and, subsequently, 
melanoma risk [100].  
 
1.3.6 MITF  
Microphthalmia transcription factor (MITF) E318K located at chromosome position 3p13, 
has recently been identified as a medium penetrance melanoma gene [127, 128], as well as 
contributing to increased naevus count [30]. It is hypothesised that MITF influences naevus 
count [101] and melanoma susceptibility through transcriptionally regulating MTAP, and 
playing a primary role in melanocyte growth and pigmentation [128]. A rare coding variant,   
E138K impairs MITF SUMOylation. This mutation has been genetically linked with increased 
naevus count, five-fold increase in melanoma incidence and development of multiple 
primary melanoma in French, UK, Australian and Italian populations [101, 127, 129]. 
Phenotypically, carriers of the E138K mutation have been reported to have a fair 
complexion, but also displayed freckling over extensive surfaces of the body and non-blue 
eye colour in an Australian population [127].  
 
1.3.7 HERC2/OCA2 
The OCA2 Melanosomal transmembrane protein (OCA2) locus located at chromosome 
15q12-q13.1, encodes the P protein, which has many functions in pigmentation.  It is 
involved in the trafficking and processing of TYR [130]. In addition, it is suspected to be 
involved in tyrosine transport [131]. Finally, it is involved in anion transport through 
modulation of the chloride conductance from melanosomes [132].  Polymorphisms 
surrounding OCA2 also contribute to eye colour pigmentation. Multiple SNPs of OCA2, span 
in to the intergenic region and encompass the 3’ end of the upstream gene, HECT and RLD 
domain containing E3 ubiquitin protein ligase 2 (HERC2) located at chromosome position 
15q13.1  [133].  It is thought SNPs located within or upstream of the regulatory region of 
OCA2 are in linkage disequilibrium with functional elements of HERC2 gene [134]. It is also 
hypothesised that HERC2 may regulate OCA2 expression [134]. The larger HERC2/OCA2 
region contributes jointly to pigmentation in hair, skin and eye colour phenotypes. In 
particular, multiple polymorphisms at this locus form the genetic basis of blue, green and 
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brown eye colour, particularly in European populations [31]. The intensity of pigmentation 
and eye pigmentation colour can be mostly explained by a single SNP, rs1291382T/C which 
lies in a highly conserved sequence within an intron of HERC2 [135]. In GWAS studies, 
rs12913832*C/T is associated with blue-brown eye colour, where the C allele at a frequency 
of 69% contributes to blue eye colour and the T allele at a frequency of 31% is associated 
with brown eye colour  [30, 136]. Additional associations for blue/non-blue eye colour are 
also reported for three HERC2/OCA2 SNPs: rs7495174 T/C 
(P=1.02×10−61), rs6497268 G/T (P=1.57×10−96), and rs11855019 T/C (P=4.45×10−54) [137]. 
SNP rs7495174 is associated with blue vs brown eye colour (P=3x10-24), while rs1667394 
(P=1.5x10-53) is associated with blue vs green eyes [31]. In addition, coding polymorphisms 
of the OCA2 protein including R305W (rs1800401) (P=0.05), R419Q (rs1800407) (P=0.09) 
and V443I (rs121918166) that are associated with eye colour [138].  
OCA2 has been demonstrated to influence eye and hair colour [31] and individuals affected 
by OCA2 mutations present with albinism, and are at significantly increased risk of sun-
induced cancers, including melanoma [139]. In a GWAS study, multiple SNPs within the 
HERC2/OCA2 region were associated with melanoma risk. The HERC2 SNP rs112903 
showed the highest level of significance with melanoma risk (P=2.58x10-8), followed by 
rs12913832 (P=4.31x10-8) and rs1800407 (P=0.004) [136]. SNP rs4778138 (P=6.52x10-4) 
and rs73377792 (P=6.3x10-4) also had a suggestive association with melanoma risk [136].  
 
1.4 Risk assessment and surveillance in high risk individuals 
Screening high risk individuals has been proven to enable earlier identification of melanoma 
and reduced costs of unnecessary excisions of benign lesions [140-142]. A standardised 
risk prediction model, adopted by international dermatology bodies, may be beneficial to the 
field, similar to breast and bowel cancer screening campaigns [143, 144]. However, we do 
not have a consensus on what constitutes a high risk classification, let alone how best to 
identify high risk individuals [145, 146]. While there is general agreement that factors like 
pigmentation (hair, skin and eye colour), naevus count, freckling, geographical location, UV 
exposure, sunburn history, family history, personal melanoma history and genetic variants 
all modulate melanoma risk, the relative contribution of each has yet to be agreed upon.   
 
Multiple melanoma risk prediction models have been proposed in an effort to provide a 
simple and reproducible method to characterise and identify high risk patients [147, 148].  
Notable differences across studies include choice of model design and analysis, method of 
17 
 
determination and definition of what constitutes a ‘high risk’, and cut off scores or thresholds 
[71, 93, 149, 150]. This makes direct comparison of models and overall model performance 
challenging. Stratification models differed in study design, e.g. case-control versus 
prospective cohort studies, potentially altering the sensitivity and specificity outcomes [145].   
 
Selection of included risk predictive parameters was also a significant variable between 
studies. In a model proposed by MacKie et al, only four model predictors were included to 
assess risk: sex, total naevus count, presence of atypical naevi, and freckling propensity 
[151]. However, in models like those proposed by Quereux et al and Fears et al, up to ten 
model predictors were included [93, 152]. These incorporated the total number of naevi, 
naevus size, the number of sun burns, personal melanoma history, family history, age and 
geographical location. Phenotypic traits such as hair colour, skin colour and freckling were 
also commonly included in a variety of studies [93, 149, 150, 152-154]. This variation in 
inclusion criteria indicates a lack of consensus in what is considered relevant and important 
for deciding an individual’s predicted risk. In a systematic review, Olsen et al concluded that 
the number and nature of predictive risk factors included in models influenced the sensitivity 
and specificity [145]. Usher-Smith et al also noted in their systematic review that risk factor 
selection in studies overall was not justified by authors, and some risk factors such as hair 
colour, skin colour and sunburn history were open to subjectivity and recall bias [148].  
 
Altman et al stated that for a model to be beneficial it must be able to perform in both the 
development data set and in additional patient cohorts [149, 155]. While the literature 
contains multiple models, the primary limitation of the majority of proposed studies was the 
lack of validation in external populations. Only those by Fortes et al and Olsen et al have 
validated a proposed melanoma risk model [146, 149]. Fortes et al was able to demonstrate 
in an Italian and Brazilian population, a reproducible AUC value (0.79 (95% CI: 0.75-0.82) 
Italian vs 0.79 (95% CI: 0.70-0.86) Brazilian). This was taking into account the fact that the 
Brazilian population was older and contained more participants with fewer naevi in 
comparison to the Italian population. They were also able to accurately classify at-risk 
individuals in 89% of the Italian and 80% of the Brazilian population [149].  
 
Ultimately, melanoma prediction models need to aid clinicians in targeting at-risk individuals 
so appropriate patient management and preventative measures can be in place. To do this, 
a successful risk prediction model needs to be generalizable and capable of being calibrated 
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to the population in which it would be applied. This can be achieved through appropriate 
selection of population specific cut-off values. Continued validation of models is required so 
that these models may become a clinical application reality [145].  
 
1.5 Surveillance in high risk individuals 
Melanoma, along with other keratinocyte cancers, are among the most frequently diagnosed 
cancers, and contribute a high economic burden to health care systems [140]. Melanoma 
mortality is strongly dependent on melanoma thickness at diagnosis [156]. Patients 
diagnosed with a melanoma less than 0.76 mm thick have significantly higher 5-year survival 
rates (98%) compared to individuals diagnosed with thicker lesions [156]. Early melanoma 
detection and diagnosis would therefore seem essential in achieving a superior long-term 
survival prognosis [156, 157].  
 
General population-based screening is not recommended by Australian or other 
international authority bodies, due to insufficient evidence in efficacy of reducing melanoma 
mortality rates, as shown in randomised controlled intervention studies, and insufficient 
evidence of cost effectiveness, based on theoretical models which assume effectiveness of 
cost and screening [158, 159]. However, physician led screening for identified high risk 
individuals is encouraged by clinical guidelines, which recommend a regular screening every 
six months along with patient self-examination [159, 160]. Targeted high risk screening has 
been demonstrated to be a cost effective strategy and less expensive than standard care in 
high risk individuals; it reduces excisions of suspicious lesions and leads to earlier detection 
of initial and subsequent melanomas [140-142, 161, 162]. 
 
 While these studies showed the benefits of screening for high risk individuals, further 
research in this area is still required. The current studies are limited by the lack of 
comparative methods and protocols of surveillance, which are unlikely to be tested due to 
ethical requirements. Current research is also often done in city-based hospital settings, 
which may reduce costs compared to primary care practices such as skin clinics or 
dermatology practices. The level of technology and specialised expertise available would 
also contribute to the reported reduction of excisions, and again, may not transfer to other 
primary care settings. Other aspects of surveillance which should be taken into account 
include good patient education for skin self-examination in interim screening periods and 
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patient confidence and compliance in conducting skin examinations, as well as additional 
patient costs (i.e. patient travel costs).  
 
1.6 Summary of literature review and scope of thesis  
To date, a valid, reproducible method for efficient assessment of naevus number and 
distribution is yet to be established. A method which classifies individuals into distinct clinical 
groups based on naevus distribution across anatomical sites may offer an alternate method 
for clinicians estimating an individual’s TNC in a time effective manner in the clinical setting.  
This research aims to characterise and classify naevus distribution patterns in a sample 
population. By combining this data with other known melanoma risk factors, it is hoped that 
this will further the development of a holistic risk stratification algorithm for melanoma, 
capable of sensitively and specifically identifying individuals at increased risk.  
 
1.7 Research question 
Are there clinically distinct naevus distribution patterns of naevi greater than 5 mm that can 
be observed in a population? 
 
1.8 Project aims and hypothesis  
The primary aim of this study is to ascertain whether patterns of naevus distribution exist 
and can be identified and classified within this study population. In addition, this research 
aims to address the current limitations of clinical application of total body naevus count by 
establishing a classification tree model based on naevus distribution pattern alongside 
known phenotypic and genotypic traits to identify individuals for surveillance. We envisage 
that this diagnostic tool will be applied clinically for rapid assessment and identification of 
individuals at risk, by integrating known melanoma risk factors with individual genotypic and 
phenotypic traits.  
 
Reasoning: A method of clinical assessment to stratify at risk individuals for cutaneous 
melanoma using naevus distribution pattern. 
 
Hypothesis 1 – Clinically distinct naevus distribution patterns can be identified and classified 
in a population, when accounting for naevi ≥ 5 mm.  
Aim 1 – Define naevus distribution patterns based on naevus anatomical site for naevi ≥ 5 
mm.  
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Hypothesis 2 – There is no correlation between hair and eye pigmentation and naevus 
distribution pattern for naevi ≥ 5 mm, in the Brisbane Naevus Morphology Study population.  
Aim 2 – To explore and define the link between hair and eye pigmentation and naevus 
distribution pattern in the Brisbane Naevus Morphology Study population.  
 
Hypothesis 3 - Germline genotype does not influence naevus distribution pattern for naevi 
≥ 5 mm.  
Aim 3 – To determine if there is a correlation between naevus distribution pattern of naevi ≥ 
5 mm and single nucleotide polymorphisms (SNPs) in the germline genotype.  
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CHAPTER 2. CLINICAL MATERIALS AND METHODS 
 
This thesis is based on a sub-set of data from a retrospective study. Images and data were 
collected and analysed from participants in the Brisbane Naevus Morphology Study (BNMS) 
[163-165]. This study was approved by the Human Research and Ethics Committee at 
Princess Alexandra Hospital (approval #HREC/09/QPAH/162, 26 August 2009) (Appendix 
1) and The University of Queensland (approval #2009001590, 14 October 2009) (Appendix 
2). This study was carried out in accordance with the principles of the Declaration of Helsinki. 
All participants were provided with a Participant Information and Consent Form. Participants 
were required to give written informed consent to participate in the research program.  
 
2.1. Brisbane Naevus Morphology Study methods 
 
2.1.1. Participant selection and recruitment  
The BNMS was conducted from October 2009 to March 2016 and recruited participants from 
the South-East Queensland region, Queensland, Australia. Selected participants included 
individuals diagnosed with melanoma or familial melanoma history. Participants were 
recruited through the Princess Alexandra Hospital Melanoma Unit, private dermatology and 
surgery clinics in Brisbane, Queensland or by direct contact. A convenience sample of 
participants with no melanoma history at the time of recruitment was compiled from hospital 
staff, previous participants of the Brisbane Twin Naevus Study or the QSkin Study [166, 
167]. These participants were age and sex matched to participants within the melanoma 
history group. Convenience sample participants were contacted directly and invited to 
participate. A total of 1254 participants completed all stages of the research program. 753 
participants were in the final melanoma group (personal or familial melanoma history) and 
501 participants were in the convenience sample group.  
 
2.1.2 Data collection 
Information was collected from participants at baseline using a questionnaire, including 
sociodemographic details, medical history, sun behaviour prevention practices, level of sun 
exposure and melanoma history. Information was collected by a research assistant. All 
participants underwent a total body skin examination by a trained research nurse or research 
assistant. Naevi ≥ 2 mm and ≥ 5 mm were counted across 16 anatomical body sites (Figure 
1), excluding areas covered by underwear, the scalp, mucosal surfaces and the soles of the 
feet in both sexs. Participants underwent total body photography with either the Vectra® 
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WB360 3D total body imager (Canfield Scientific Inc., NJ USA) or FotoFinder® (Bad 
Birnbach, Germany) imaging system. Naevi ≥ 2 mm and ≥ 5 mm were digitally documented 
using dermoscopy [164].   
 
Participants also underwent clinical assessment by a trained research assistant. Natural hair 
colour at age 21 years (5 categories), eye colour (3 categories), skin colour (3 categories) 
and freckling density on the face, shoulders and dorsal right hand (4 categories) were 
documented using a scale system (Table 1). Skin colour spectrophotometer readings were 
taken using a hand held spectrophotometer (Konica Minolta). Height, weight and BMI was 
also collected. Participants also provided a saliva sample for genomic sequencing with an 
Oragene-DNA self-collection kit (DNA Genotec, Ottawa, ON, Canada). DNA was processed 
at the UQ Centre for Clinical Genomics and genotyping was performed on the Illumina 
Infinium HumanCoreExome 24 Microarray.  
 
Naevus dermoscopy images were measured by a trained research assistant using the 
ImageJ measuring tool. Count for melanocytic naevi ≥ 2 mm and ≥ 5 mm were separately 
documented for each anatomical region in every participant. Total body naevus count and 
naevus count at each anatomical site was recorded in a database.  
 
Table 1: Clinical measurement of pigmentation traits documented in participants in the 
Brisbane Naevus Morphology Study protocol. 
 Pigmentation Characteristics  
Eye Colour Blue/Grey 
Green/Hazel 
Brown 
Natural Hair Colour at age 21 Red/Auburn 
Fair/Blonde  
Light Brown 
Dark Brown 
Black 
Skin Colour  
 Innate skin colour (ventral upper arm) 
 Facultative skin colour (dorsal forearm) 
Fair 
Medium 
Olive 
Freckling score 
 Face  
 Dorsum right hand 
 Shoulders 
None 
Mild 
Moderate 
Severe 
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2.2 Classification of naevus distribution pattern study method 
 
2.2.1 Participant selection 
Eligible study participants were selected from the Brisbane Naevus Morphology Study. 
Selected participants had varying melanoma status and included individuals with personal 
or familial melanoma history or no melanoma history. Selected participants were ≥ 18 years 
old, and there was no maximum age limit. Participants were excluded if they were <18 years 
of age, had incomplete anatomical naevus counts or total body naevus counts, or had 
missing clinical data from the BNMS database. For the purpose of this research, naevus 
counts from 2-5 mm were excluded. Only naevi ≥ 5 mm were included minimise false 
positives, ensuring that selected naevi were true naevi and that naevus counts were 
therefore valid. Project time limitations were also a contributing factor. A total of 1225 
participants (51.8% female, 48.2% male) met study inclusion criteria from the BNMS cohort. 
29 participants were excluded from this study because they had incomplete naevus count 
data sets, or were outside the specified age criteria. 
 
2.2.2 Data collection 
For this project, only naevi ≥ 5 mm located the head and neck, back, chest and abdomen, 
upper limbs (including upper arms, forearms and hands) and lower limbs (including upper 
legs, lower legs, and feet) were included for analysis.  A total of five anatomical regions were 
selected for naevus analysis (Figure 1). Age, sex, hair and eye colour as well as melanoma 
history were extracted from the original BNMS clinical examination reports and included with 
naevus count data for each participant. Genotype data was extracted from original BNMS 
data spreadsheets and from the Dermatology Research Centre SNPs records for the BNMS 
participants.        
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2.2.3 Statistical analysis 
Summary statistics were calculated for naevus counts and participant characteristics from 
participants’ baseline visits. Naevus counts were compared between male and female 
participants using a Mann-Whitney test, and across clusters using ANOVA. Categorical 
variables were analysed using chi-square tests, or fishers exact test as appropriate.  
 
2.2.4 Cluster analysis to identify naevus distribution patterns 
Naevus counts were analysed using different methods of cluster analysis to determine if 
naevus pattern of distribution could be identified. Cluster analysis is best described as an 
exploratory data analysis technique. It aims to partition or ‘cluster’ similar observations of 
data into naturally alike groups, in which the number of groups as well as the parameters of 
the group, are unknown. In doing so, similar features and data patterns can be extracted, 
explored and classified [168]. The models and methods of cluster analysis are vast. Each 
method has a variety of distance measures to determine the level of similarity or dissimilarity 
between clusters. This is important to note when assessing clusters, due to the absence of 
a p-value. The cluster analyses in this study were performed using two methods, k-means 
approach with the Gower method and Euclidean distance used as a measure of similarity 
Figure 1: Schematic diagram of the five nominated anatomical regions selected for assessing 
naevus distribution pattern in naevi ≥ 5 mm. The total body was divided into the head and neck, 
the back, the chest and abdomen, the upper limbs, including the upper arms, lower arms and 
hands and the lower limbs, including the thighs, lower legs and feet.  
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and dissimilarity between clusters (StataCorp LP, USA) (see below, Section 2.2.5 for more 
detail), and the Gaussian Mixture modelling using the mclust package in R 3.5.0  [169, 170] 
(discussed further below Section 2.2.6).  
 
2.2.5 K-means analysis  
K means analysis is one of the most common forms of clustering. This approach can be 
hierarchical or non-hierarchical in nature. For the purpose of this research, a non-
hierarchical approach to k-means was adopted due to the large scale of the data set and 
the ability to reassign data observations as the clustering process progresses [168]. The 
pseudo-F statistic describes the ratio of variability between clusters as well as within a 
cluster. Clustering is optimal when observations are more homogenous and cluster variance 
is minimal. The number of clusters with the maximal F-index statistic is deemed to be the 
optimal number of clusters.     
 
K-means cluster analysis was performed using baseline data, including naevus counts for 
total body naevus count (including the head and neck), the back, chest and abdomen, the 
upper limbs and lower limbs, and participant sex and age. Cluster analyses was performed 
to assess if naevus distribution patterns could be identified within the selected participant 
population. Two cluster analyses were performed using k-means analysis.  
 
Variables incorporated in the first cluster analysis included number of naevi at each 
anatomical site, sex and age. All variables were standardised, excluding sex, so as to put 
discrete and continuous variables on the same scale. Variables were then subjected to non-
hierarchical cluster analysis, calculating scenarios with 2 to 12 cluster solutions. The 
pseudo-F index was used to assess when the optimum clustering solution was attained. For 
sensitivity analysis, k-median approach was used to determine if the same pseudo-F index 
was obtained. The Gower method for mixed data (continuous and categorical) was used as 
a measure of similarity and dissimilarity between clusters.  
 
For the second k-mean analysis, naevi number at each anatomical site was the only 
included variable. This was to determine the impact of age and sex and on naevus 
distribution. Again, variables were standardised and the optimal number of clusters was 
calculated for 2 – 12 scenarios and the pseudo-F index calculated. For consistency, the 
Gower method was also applied. The minimum, mean, maximum and p50 was reported for 
all clusters and for the sample population overall. Statistical analyses were done using 
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STATA software, version 11.0 (StataCorp LP, USA). Post-hoc comparisons of naevus 
counts within clusters were investigated using a Students t-test (GraphPad Prism Version 
7.0).  
 
2.2.6 Mclust cluster analysis 
K-means analysis data indicated that it would be more helpful to develop clusters that were 
independent of age and sex. Box-Cox regression suggested that log transformation was 
most appropriate for these data in R. Log transformed naevus counts were therefore 
adjusted for age and sex. Specifically, linear adjustments were made to data and quadratic 
adjustments were made to age fit data to the curve. Clustering analysis was done using the 
mclust package in R (version 5.4.1) [169], which is based on Gaussian finite mixture 
modelling. Gaussian finite mixture modelling uses probabilistic modelling to model the 
presence of  subpopulations within an overall population [169]. It also assumes all data has 
unknown parameters.  For more technical and in-depth review of this method, refer to see 
reviews such as Fraley and Raferty [171]. The optimal number of components or clusters 
and the most likely model is determined by the Bayesian Information Criterion (BIC). The 
model and number of components with the highest BIC value is the optimal number of 
components and most appropriate model. Models are fitted in R using the mclust package.  
 
2.2.7 Principal component analysis 
Principal component analysis, is a method which aims to reduce the number of dimensions 
and to reduce the size of a variable set of data [172]. Principal component analysis can also 
be used for feature selection. The process of principal component analysis transforms the 
number of variables which are possibly correlated, into uncorrelated combinations, which 
are called principal components [173]. In this case, principal component analysis was used 
to describe the importance of each anatomical site in separating the data. The principal 
components were then compared to the clusters.  
 
2.2.8 Classification Tree Analysis  
Finally, a classification tree model was developed to allocate individuals into the derived 
clusters, with the overall aim of assisting in clinical decision making. Classification trees are 
an analytic method where the idea is to create, creating mutually exclusive subpopulations 
which group participants based on similar characteristics. Classification trees use a non-
parametric method which recursively splits the data in order to reduce the heterogeneity of 
dependent/predicted variable [174].  Splitting rules are created based on the Gini criterion, 
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which is an impurity index. To assess the accuracy of the model and classification error, the 
dataset is divided into two, a training and a test set with a 3:1 ratio. The model is then fitted 
on the training set, and classification accuracy is calculated using the test set. Models are 
fitted in R using rpart [175].  
 
2.3 Phenotype and genotype 
Eye and hair colour and participant melanoma history was extracted from original BNMS 
data spreadsheets and from the Dermatology Research Centre SNPs records for eligible 
BNMS participants. Genotype data for eight candidate genes was collated for all 
participants. Target genes were selected based on their documented associations with 
pigmentation, naevogenesis or cutaneous melanoma (see Table 2). 
 
Participant phenotype data was collated into a single spreadsheet, linked by participant ID, 
and evaluated for any associations. Specifically, the frequencies of different phenotypes in 
within and between clusters were evaluated. To better understand the differential 
characteristics of each cluster, chi-squared or Fisher’s exact tests were used to analyse 
whether there was a relationship between a cluster and demographic, phenotypic or genetic 
characteristics or melanoma history.  
 
The relative frequency of common SNPs from the selected eight candidate genes (Table 2) 
were investigated in each cluster, and compared between different clusters.  
 
Table 2: List of selected SNPs and candidate genes assessed in the BNMS that are 
associated with pigmentation expression, naevogenesis and melanoma [30].    
 
Gene Impact on pigmentation, naevi and 
melanoma 
SNP Chr:Position 
MC1R Variants contribute to skin pigmentation, 
phototype, freckling, red hair colour, 
activation of DNA damage response in 
melanocytes, prevention of 
photocarcinogenesis. Highly 
polymorphic. 
rs1805005 
rs1805006 
rs2228479 
rs11547464 
rs1805007 
rs1110400 
rs1805008 
rs885479 
16:89919436 
16:89919510 
16:89919532 
16:89919683 
16:89919709 
16:89919722 
16:89919736 
16: 89919746 
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rs1805009 16:89920138 
    
IRF4 Melanoma, solar elastosis, dark hair 
colour, light eye colour, decreased 
tanning ability, freckling and naevus count 
rs12203592 6:396321 
MITF Regulates melanocyte differentiation, 
increased melanoma risk, multiple 
primary melanoma, familial melanoma 
risk, high naevus count, non-blue eye 
colours 
rs149617956 3:69964940 
MTAP Increase in adult naevus count, 
melanoma, tumour suppressor function  
rs7023954 
rs7023329 
rs4636294 
 
9: 21816759 
9: 21816529 
9: 21747804 
 
PLA2G6 Increased naevus count, regulates cell 
growth, apoptosis, cell proliferation of 
tumours 
rs11570680 
rs150024227 
rs143826762 
rs142530390 
rs138672490 
rs149653983 
rs147948449 
rs11570605 
rs147066967 
rs200075782 
rs144910769 
rs142715413 
rs147924368 
rs199636953 
rs201801144 
rs139184008 
rs146684391 
rs144012369 
rs149712244 
rs200117092 
22:38132881 
22:38169336 
22:38120886 
22:38145538 
22:38143275 
22:38132952 
22:38169326 
22:38169255 
22:38140069 
22:38169318 
22:38169311 
22:38145597 
22:38140006 
22:38128349 
22:38126390 
22:38126374 
22:38126371 
22:38120777 
22:38116155 
22:38116119 
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rs140758033 
rs141777179 
rs2284063 
rs132985 
22:38112165 
22:38113621 
22:38148291 
22:38167464 
CDKN2A Increased melanoma risk and familial 
melanoma risk 
rs3731249 
rs116150891 
rs146179135 
rs45456595 
rs200382984 
9: 21970917 
9:21970929 
9:21970986 
9:21974641 
9:21974721 
OCA2 Associated with blue-brown eye colour, 
Albinism type II and increased BCC risk 
rs16950821 
rs4778138 
rs1470608 
rs7174027 
rs7495174 
rs12913832 
15:28038361 
15:28090674 
15:28042975 
15:28083619 
15:28099092 
15:28120472 
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CHAPTER 3. NAEVUS DISTRIBUTION PATTERN CHARACTERISATION AND 
CLASSIFICATION BY CLUSTER ANALYSIS 
 
3.1 Study population 
Total body imaging and physical exams were performed on 1125 Australian adults from the 
Brisbane region as part of the Brisbane Naevus Morphology Study (see Section 2.1). The 
study population naevus distribution characteristics can be reviewed in Table 3. Study 
population ancestry was predominantly of European descent. There was a wide spread in 
participant age recorded, with a mean age of 47.5 ± 16 years (range 18 – 88 years). Males 
were older than females (mean 50 ± 17 years vs 44.8 ± 16 years). Overall, a high variation 
in total body naevus count ≥ 5 mm was observed within this population.  45.5% of 
participants had a TNC between 0 – 10 naevi, for naevi ≥ 5 mm. 11.5% of the participant 
population had a high TNC ≥ 50 naevi, for naevi ≥ 5 mm. A significant difference between 
total body naevus count and sexs was observed (P<0.001). Males on average tended to 
have a higher TNC than females (16.4 ± 30 vs 14.8 ± 26, P < 0.001) for naevi ≥ 5 mm. 
Regardless of sex, naevi were most likely to be located on the back (P<0.001). While women 
had a higher mean naevus count on the lower limbs, this difference was not considered 
significant (P=0.093). Naevus count on the upper limbs was not significantly different 
between sexs (P=0.926).   
 
Table 3: Anatomical distribution of naevi  5 mm by sex in 1225 Australian adults in the 
BNMS.   
 Male (N = 590) Female (N = 635)  
Anatomical Region Mean ± (SD) Mean ± (SD) P-value 
Back 10.3 ± 16 6.7 ± 10 < 0.001 
Chest/Abdomen 5.8 ± 7 3.0 ± 5 < 0.001 
Upper Limbs 3.4 ± 6 3.8 ± 6 0.926 
Lower Limbs 4.0 ± 7 5.7 ± 12 0.094 
Total Naevus Count 16.4 ± 30 14.8 ± 26 < 0.001 
 
3.2 Cluster analyses 
A spreadsheet was created summarizing all the phenotypic data, including naevus count 
and distribution, for each participant, coded according to study ID. Participants were then 
clustered according to number and distribution of naevi (according to anatomical site) as 
described in Section 2.2.4. 
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Two methodologies were pursued to identify phenotypic clusters (see Sections 2.2.5 and 
2.2.6 for details). K-means analysis classified the population into six clusters, characterised 
by age and sex first, and followed by number of naevi. Three clusters contained females 
and 3 contained males. The alternate method mclust began by adjusting for age and sex 
and then clustering according to naevus count and distribution. This generated three 
clusters. Figure 2 provides a summary of the two clustering approaches and the respective 
number of clusters identified using each method.  
 
 
Figure 2:  Method of cluster analysis and summary of cluster outcomes. 
 
 
3.2.1 K-means analysis 
Using k-means analysis, the clustering optimum was attained for a six cluster solution 
(pseudo-F = 297.20) when sex and age were included in the analysis. Due to incorporating 
of sex in k-means analysis, clusters were divided into sex, producing three all-female 
clusters (Cluster 1, 2, 3) and three all male clusters (Cluster 4, 5, 6) (Table 4).  When only 
naevus number at each anatomical site was considered in the analysis (age and sex 
excluded), the optimum number of clusters was two (pseudo–F index = 961.06).  
 
 
BNMS Cohort 
N = 1125 
K means clustering mclust clustering 
Age 
Gender 
Number of naevi 
≥5mm 
Number of naevi  
≥5mm  
6 Clusters  2 Clusters  
Adjust variables for 
age, gender 
3 Clusters  
3 Male Clusters 
3 Female Clusters 
Cluster 1: Many naevi 
Cluster 2: Few naevi  
Cluster 1: Many naevi 
Cluster 2: Some naevi 
Cluster 3: Few naevi  
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3.2.1.1 K-means with six clusters 
 
Sex and Age Included: Clusters 1 – 6 
 
Table 4: Anatomical distribution of naevi  5 mm by age and sex (n=1225). K-means 
analysis determined 6 clusters to be the optimal number of clusters. K-means clustering 
produced 3 all-female clusters and 3 all-male clusters. SD – Standard deviation 
 
 Cluster 
Characteristics 1 2 3 4 5 6 
       
Sex, n (%)       
   Female 251 (100%) 340(100%) 44 (100%) - - - 
   Male - - - 273 (100%) 253 (100%) 64 (100%) 
Age       
   Mean ± (SD) 60 (8) 33 (7) 53 (14) 35 (9) 66 (8) 52 (13) 
   Median (Range) 59 (44-85) 31 (18-49) 52 (25-81) 32 (18-54) 66 (49-88) 51 (27-81) 
TNC ≥ 5 mm       
Mean ± (SD) 18 (15) 12 (13) 94 (33) 13 (14) 20 (16) 93 (36) 
Median (Range) 13 (0-74) 7 (0-66) 83 (48-176) 8 (0-74) 16 (0-83) 85 (40-229) 
Back       
Mean ± (SD) 6 (7) 5 (7) 26 (21) 6 (8) 6 (7) 43 (25) 
Median (Range) 3 (0-46) 3 (0-36) 21 (0-96) 4 (0-41) 4 (0-45) 40 (5-119) 
Legs       
Mean ± (SD) 5 (7) 2 (4) 37 (29) 1 (3) 5 (7) 12 (14) 
Median (Range) 3 (0-54) 1 (0-28) 30 (3-130) 0 (0-25) 2 (0-37) 9 (0-71) 
Chest/Abd       
Mean ± (SD) 2 (3) 2 (3) 13 (11) 3 (4) 4 (4) 25 (12) 
Median (Range) 2 (0-15) 1 (0-23) 10 (1-52) 2 (0-19) 3 (0-20) 23 (7-59) 
Arms       
Mean ± (SD) 4 (5) 2 (3) 17 (9) 2 (3) 4 (5) 11 (11) 
Median (Range) 2 (0-28) 1 (0-31) 16 (1-41) 1 (0-21) 2 (0-33) 9 (0-76) 
       
 
 
Cluster 1: Low Back and Lower Limbs Naevus Count 
Cluster 1 consisted of 251 (20.5%) participants with a mean age of 60 ± 8 years. All 
participants in this cluster were female and had relatively low TNC ≥ 5 mm (mean 18 ± 15). 
Hence, naevus count at each anatomical site was also low. Naevi were predominantly 
located on the back (mean 6 ± 7) and lower limbs (mean 5 ± 7), followed by the upper limbs 
(mean 4 ± 5) then chest/abdomen (mean 2 ± 3) (Table 4).  
 
Cluster 2: Low Back Naevus Count 
This cluster consisted of 340 (27.8%) participants with a mean age 32 ± 7. All participants 
in this cluster were female. This was the youngest age cohort from all six clusters, ranging 
in age from 18 - 49. Participants had lower total body naevus counts ≥ 5 mm compared to 
Cluster 1 (mean 12 ± 14, P<0.0001), corresponding to lower naevus counts at each 
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anatomical site.  Naevi ≥ 5 mm were predominantly distributed to the back (mean 5 ± 7). 
Distribution of naevi was even across the chest/abdomen, and upper and lower limbs with 
a mean count of 2 ± 3 at each site (Table 4). 
 
Cluster 3: High Trunk and Lower Limb Naevus Count 
Cluster 3 contained 44 (3.6%) participants with a mean age of 53 ± 14. Again, this cluster 
was all female. Compared previous two female clusters, participants in Cluster 3 reported 
the highest TNC ≥ 5 mm (mean 94 ± 3). Correspondingly, participants in Cluster 3 also had 
the highest naevus count at each anatomical site. Naevi ≥ 5 mm were predominantly 
distributed to the lower limbs (mean 36 ± 29) and back (mean 25 ± 21) (Table 4).  
 
Cluster 4: Low Trunk Naevus Count 
Cluster 4 consisted of 273 (22.3%) participants with a mean age of 34 ± 9 years. This cluster 
was all male and had a relatively low TNC ≥ 5 mm (mean 12 ± 14). Naevus counts ≥ 5 mm 
at each anatomical site were also low and predominantly distributed to the back (mean 6 ± 
8) followed by the chest/abdomen (2 ± 4). Naevi ≥ 5 mm present on the upper and lower 
limbs were similarly distributed and low in count (Table 4).      
 
Cluster 5: Low Back and Lower Limbs Naevus Count 
253 (20.7%) participants with a mean age of 66 ± 8 years made up this cluster. Cluster 5 
had the oldest mean age for all male clusters (Clusters 4, 5 and 6). Cluster 5 had relatively 
low TNC ≥ 5 mm (mean 20 ± 16), though they were slightly higher than those in Cluster 4. 
Naevus count ≥ 5 mm was highest on the back (6 ± 7) and the lower limbs (5 ± 7). Naevus 
counts ≥ 5 mm for the chest/abdomen and upper limbs were also low (Table 4).  
 
Cluster 6: High Trunk Naevus Count 
The final cluster consisted of 64 (5.2%) participants with a mean age of 52 ± 13 years. Like 
clusters 4 and 5, this cluster was all male. Cluster 6 was an older age cohort in comparison 
to Cluster 4 but a lower age cohort compared to Cluster 5. Participants had a significantly 
higher TNC ≥ 5 mm (mean 93 ± 36, P < 0.001) with naevi heavily concentrated on the back 
(43 ± 25) and chest/abdomen (25.2 ± 12 ≥ 5 mm). Naevi ≥ 5 mm were significantly reduced 
on the upper and lower limbs in individuals in this cluster compared to participants in Cluster 
4 (P<0.0001) and 5 (P<0.0001) (Table 4).      
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3.2.1.2 K-means with two clusters 
 
Naevus Count Only (Sex and Age Excluded): Cluster 1- 2  
 
Table 5: Anatomical distribution of naevi  5 mm by naevus number (n=1225). Age and sex 
were excluded variables in this analysis. K-means analysis determined 2 clusters to be the 
optimal number of clusters. SD – Standard deviation 
 
 Cluster 
Characteristics 1 2 
   
Sex, n (%)   
   Female 54 (40%) 581 (53%) 
   Male 81 (60%) 509 (47%) 
Age   
Mean ± (SD) 54 (14) 47 (17) 
Median (Range) 53 (24-81) 46 (18-88) 
TNC ≥ 5 mm   
Mean ± (SD) 87 (34) 14 (13) 
Median (Range) 77 (42-229) 10 (0-80) 
Back   
Mean ± (SD) 33 (22) 6 (6) 
Median (Range) 30 (0-119) 3 (0-45) 
Legs   
Mean ± (SD) 21 (13) 3 (5) 
Median (Range) 30 (0-130) 1 (0-67) 
Chest/Abd   
Mean ± (SD) 18 (12) 3 (3) 
Median (Range) 15 (0-59) 2 (0-25) 
Arms   
Mean ± (SD) 14 (11) 2 (3) 
Median (Range) 11 (0-76) 1 (0-26) 
 
 
 
Cluster 1 – High Naevus Count 
The first cluster consisted of only 11% (n=135) of the total number of participants. 
Participants had a mean age of 54 ± 14 years, ranging from 24 – 81 years. In total, 40% of 
the cluster population was female. Overall, participants in Cluster 1 were characterised by 
a high TNC ≥ 5 mm (mean 87 ± 34). Overall, naevi ≥ 5 mm were distributed on the trunk, 
with naevus counts reported to be highest on the back (mean 32 ± 24) followed by the 
chest/abdomen region (mean 18 ± 12). Naevus counts ≥ 5 mm were also high on the legs 
and arms in Cluster 1 participants (Table 5).  
  
Cluster 2 Low Naevus Count 
The second cluster consisted of the majority of the participants (n=1090, 89%) and had a 
mean age of 47 ± 17 (range 18 – 88). In Cluster 2, 53% of the population was female. 
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Significantly lower TNC ≥ 5 mm was recorded for this cluster compared with Cluster 1 (mean 
14 ± 13, P<0.0001). Naevi ≥ 5 mm were predominantly located on the back (mean 6 ± 7) 
and the legs (mean 3 ± 5). Naevi ≥ 5 mm were only slightly lower on the chest/abdomen and 
the arms compared to Cluster 1 participants (P<0.0001). 
 
3.2.2 Mclust analysis  
In addition to the k-means analysis, mclust [169] was employed. Three clusters were 
determined to be the optimal number of clusters following the VVE criteria of the mclust 
analysis (Figure 3). This model was adjusted for age and sex, with nevus counts at each of 
the five body sites inputted into the clustering model (see Section 2.2.6). Briefly, total naevus 
count varied significantly across all clusters (P<0.0001) (Figure 4).  The counts of naevi ≥ 5 
mm were not uniformly distributed across all anatomical regions (Figure 5), with varying 
distribution trends between clusters. However, across all clusters and anatomical sites, the 
greatest number of naevi was on the back. The back was therefore a consistent feature in 
all patterns of naevus distribution and was considered an important site when assessing 
pattern of naevus distribution. The three clusters are described in greater detail below.  
 
Figure 3: Performance of mclust models by cluster number. Variables were adjusted for age 
and gender. Bayesian Information Criterion (BIC) are plotted against number of clusters for the 
14 models tested by mclust. The model and number of clusters with the highest BIC value is 
determined to be the optimal model and best model of fit. From this data, model based clustering 
has determined that three components (clusters) is optimal with covariances described as 
ellipsoidal in distribution, with equal orientation and variable volume and shape (See purple line, 
VVE). VVE = Variable volume, variable shape, ellipsoidal, equal orientation. 
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Cluster 
     Total Body Count of Naevi ≥ 5 mm 
Figure 4: Box and whisker plots of total body naevus count  5 mm in participants across 3 
clusters from the mclust analysis. Outlier observations are marked with an open circle. 
 
 
Figure 5: Box and whisker plot of anatomical distribution of naevi ≥ 5 mm. Participants in the BNMS were stratified into 3 clusters based on the 
anatomical counts of naevi ≥ 5 mm at each site. Data was adjusted for age and gender. Cluster 1 contained participants with the highest naevus 
count at all anatomical sites, and highest overall TNC. Cluster 2 and 3 contained participants with considerably reduced naevus counts at each 
anatomical site and lower TNC. The back had the highest naevus count across all 3 clusters. Outlier observations are marked with an open circle. 
Cluster 
Anatomical Distribution of naevi ≥ 5 mm 
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Adjusted for Age and Sex: Cluster 1 - 3  
 
Table 6: Cluster profiles for mclust showing anatomical distribution of naevi  5 mm 
(n=1225). Variables were adjusted for age and sex. SD – standard deviation.  
 
 Cluster 
Characteristics 1 2 3 
    
Sex, n (%)    
   Female 207 (51.5%) 279 (50.5 %) 136 (55.3%) 
   Male 220 (48.5%) 273 (49.5%) 110 (44.7%) 
Age    
   Mean ± (SD) 49 (16) 51 (17) 38 (14) 
   Median (Range) 49 (18-88) 51 (18-87) 31 (18-82) 
TNC ≥ 5 mm    
   Mean ± (SD) 49 (34) 10 (6) 4 (5) 
   Median (Range) 38 (7-229) 9 (1-33) 2 (0-36) 
Back     
Mean ± (SD) 18 (18) 4 (3) 2 (3) 
Median (Range) 13 (0-119) 3 (0-23) 1 (0-16) 
Legs    
Mean ± (SD) 12 (15) 2 (2) 0 (0) 
Median (Range) 7 (0-130) 1 (0-21) 0 (0-13) 
Chest/Abd    
Mean ± (SD) 9 (10) 2 (3) 1 (2) 
Median (Range) 6 (0-59) 1 (0-14) 2 (0-19) 
Arms    
Mean ± (SD) 8 (8) 2 (2) 0 (0) 
Median (Range) 6 (0-76) 1 (0-12) 0 (0-2) 
    
 
 
Cluster 1: High naevus count  
Cluster 1 contained 427 (34.9%) participants with a mean age of 48 ± 16 years (Table 6). 
52% of participants were female. Participants in Cluster 1 had a high TNC ≥ 5 mm (mean 
49 ± 34). Participants in this cluster had naevi ≥ 5 mm predominantly located on the trunk, 
with most naevi distributed to the back (18 ± 18) followed by the chest/abdomen. Fewer 
naevi ≥ 5 mm were counted on the upper and lower limbs compared to the back and chest. 
However, naevi counts  5 mm on the upper and lower limbs were on average higher in this 
cluster than Cluster 2 and Cluster 3 (P<0.0001). 
 
Cluster 2: Low naevus count  
Cluster 2 constituted 552 (45%) participants with a mean age of 50 ± 16 years (range 18 – 
87) (Table 6). 51% of participants were female. Participants in Cluster 2 had an overall lower 
TNC ≥ 5 mm (mean 10 ± 6, P<0.0001) and lower naevus count at each anatomical site in 
comparison to Cluster 1 (P<0.0001). Additionally, participants in Cluster 2 had a significantly 
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higher TNC than Cluster 3 participants (P<0.0001).  Participants within this cluster were 
characterised predominantly by naevi ≥ 5 mm located on the back (mean 4 ± 3). The back 
had the highest naevus count compared to other anatomical sites for participants in this 
cluster.  
 
Cluster 3: Minimal naevus count 
The final cluster consisted of 247 (20.2%) participants with a mean age of 38 ± 14 years 
(Table 6). 55.3% of participants were female. Overall, Cluster 3 contained participants with 
the lowest naevus counts ≥ 5 mm across all three clusters (mean 4 ± 5, P<0.0001). 
Participants in Cluster 3 were younger on average compared to Cluster 1 and 2 participants 
(P<0.0001).  Naevi  5 mm were most frequently featured on the back in Cluster 3 
participants (2 ± 3). Naevus counts to the chest/abdomen were low (mean 1 ± 2), while naevi 
≥ 5 mm on the upper and lower limbs were negligible (mean ≤ 1).  
 
3.2.3 Choice of final clustering approach 
 
Three possible outcomes were obtained from the two models of cluster analysis.  A set of 
six clusters and a set of two clusters were produced using k-means analysis and three 
clusters using mclust. K-means clustering with six final clusters provided an expected 
outcome, in that sex-specific body site naevus distribution patterns were observed (i.e. 
women had higher distribution to the legs and back, men had higher distribution to the trunk). 
These differences were more defined in men and women with higher total naevus counts 
(TNC > 90, Cluster 3 and 6), which accounts for approximately 9% of the study population 
(Table 4). In the remaining clusters determined by k-means analysis, similar overlapping 
features of naevus pattern outcomes were observed between sexes. The two cluster model 
from k-means analysis was too simplistic, as this model only described individuals with many 
naevi or very few naevi (Table 5). Similar to the six clusters, there was no clear pattern 
distribution identified from the two clusters; therefore, it would not be useful clinically. A more 
clinically useful tool would be non-sex and non-age specific. A model based approach 
(mclust) was applied where naevus counts were adjusted for age and sex. Three patterns 
of naevus distribution were found to be optimal with this model. This model produced more 
identifiable naevus patterns across the anatomical sites, and will therefore be used for the 
remainder of the thesis.  
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3.2.4 Comparison of principal component analysis to clusters 
Principal component analysis was used to provide further exploratory information, using 
feature selection to optimise separation of the data by naevus counts and by body site. Two 
principal components explained 83% of the variation in the data (Table 7):   
 Principal component 1 (PC1) explained the majority of the variance (64.6%) within 
the dataset, with a further 18.5% explained by principal component 2 (PC2). All four 
anatomical sites (legs, arms, chest/abdomen, and back) correlated positively with 
component 1, with the back having the highest loading (Table 8). This indicated that 
naevus counts as an independent variable may be sufficient as a clinical tool to 
separate the participants in the dataset. 
 Principal component two (PC2) was positively correlated with leg and arm counts, 
and notably negatively associated with chest/abdomen and back counts (Table 8). 
This indicated that further separation is gained between participants who have 
increased arm and leg counts, but decreased back and abdomen counts. A visual 
representation of this separation can be seen in Figure 6 where the clusters are 
represented by colour (Cluster 1 (red), Cluster 2 (green), Cluster 3 (blue)). Cluster 1 
observations were more spread in comparison to Cluster 2 and 3, indicating there is 
greater variation in this cluster in terms of the naevus counts (Figure 6).  
 
Table 7: Variance explained by the first four principal components.  
 
Table 8: Principal component analysis. Contribution of each variable is listed as a loading 
within each component.  
Loadings Comp 1 Comp 2 Comp 3 Comp 4 
adjLegs 0.480 0.672 0.563 - 
adjArms 0.451 0.359 -0.803 -0.151 
adjChestAbd 0.469 -0.461 0.194 -0.728 
adjBack 0.589 -0.456 - 0.668 
Importance of 
Components 
Comp 1 Comp 2  Comp 3 Comp 4 
Standard deviation 0.6717 0.3595 0.2543 0.2302 
Proportion of variance 0.6463 0.1852 0.0926 0.0759 
Cumulative proportion 0.6463 0.8314 0.9241 1.0000 
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       Cluster Distribution  
High ChestAbd naevus count  
High Back naevus count 
High Arms naevus count  
High Legs naevus count 
 
Figure 6: Biplot of principal component analysis of 3 clusters. Principal components are 
comprised of linear combinations of the inputted variables (nevus counts by anatomical site) and 
highlights homogenous individuals. Together, PC1 and PC2 explain 83% of the variance within 
the data set. PC1 does a reasonable job of separating the three clusters predefined by mclust. 
Cluster 1 is a distinctive cluster to the left of the graph (shown with red points). Less differentiation 
is seen across PC2 (y axis). Cluster 2 (green) is located between Cluster 1 and overlaps slightly 
with Cluster 3 (blue). As shown by the component loadings in Table 8, Cluster 1 is characterised 
by higher values of all naevus counts for all the four anatomical sites (back and chest/abdomen, 
legs, arms).  
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3.2.5 Decision trees: A clinical tool to assign individuals to clusters 
Decision trees are a simple tool that can be used to cluster individuals, in this case clustering 
them into the three naevus distribution patterns. As mentioned in Chapter 2.2.7 the following 
variables were included in the tree: age, eye colour, hair colour, TNC and naevus counts 
individually for the legs, arms, chest/abdomen and back. From the above variables, four 
were included in the final model. The most important variable to separate individuals by 
cluster was TNC  5 mm. A cut off value 21 TNC was determined as optimal as the first 
branch of the decision tree. The remaining variables in the decision tree were leg counts, 
age and arm counts (Figure 7). Classification Tree 1 had an overall accuracy of 90% in 
assigning an individual to a correct cluster (95% CI 86%-93%). Additional statistics for 
Classification Tree 1 are shown in Table 9.  
 
 
 
 
 
 
 
 
Figure 7: Classification Tree 1 including whole body naevus count ≥ 5 mm. Included variables are 
whole body naevus count, upper limb count, and lower limb count for naevi ≥ 5 mm. Age is also 
included. Classification tree 1 had a predictive accuracy of 90%. As an example, if an individual 
presented in the clinic with the following Total body counts: 10, Back counts: 5, Chest counts: 2, Arm 
counts: 3, Leg counts: 0, Age: 35 the following pathway and rules of the classification tree would apply:  
Whole body < 21, legs < 1, arms ≥ 1. Therefore the individual would be allocated to Cluster 2 (Blue).  
The positive predictive value associated with belonging to cluster 2 is 88%. Therefore if the person is 
allocated to Cluster 2 using the following cut-offs there is an 88% chance this allocation is correct.                           
Total naevus count 
Naevi 
Naevi 
Naevus 
Naevus 
Naevus 
Naevus 
Years 
Years 
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Table 9: Accuracy of Classification Tree 1 (including whole body naevus count ≥ 5 mm).  
 Cluster 1 Cluster 2 Cluster 3 
Sensitivity 87% 91% 94% 
Specificity 94% 90% 100% 
Positive Predictive Value 89% 88% 98% 
Negative Predictive Value 93% 93% 98% 
 
Total body naevus counts are not routinely conducted in the clinical setting. Therefore, 
Classification Tree 2 excluded total body count. In this decision tree the most important 
variable in separating individuals into clusters was back counts (Figure 8). To apply the flow 
chart clinically, the clinician would only need to count to the appointed threshold (≥ 9 naevi 
of ≥ 5mm), which can be done in much less time than TNC. In individuals with naevi counts 
<9, the number of the naevi on the legs and arms are counted to complete classification and 
allocate to cluster. The overall accuracy of the second model was slightly less at 88% (95% 
CI: 84%-91%) (Table 10). 
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Table 10: Accuracy of Classification Tree 2 excluding whole body naevus count. 
 Cluster 1 Cluster 2 Cluster 3 
Sensitivity 90% 85% 90% 
Specificity 88% 92% 100% 
Positive Predictive Value 80% 90% 100% 
Negative Predictive Value 94% 87% 98% 
  
  
Figure 8: Classification Tree 2 excluding whole body naevus count ≥ 5 mm. Variables included 
are back count, upper limb count, and lower limb count for naevi ≥ 5 mm. Classification tree 2 
had predictive accuracy of 88%. If we use the example individual from Classification tree 1 who 
presents with a total body count: 10, back count: 5, chest/abdomen count: 2, upper limb count: 
3, lower limb count: 0, Age: 35, the following pathway of the classification tree would apply:  Back 
<9, legs <1, arms >=1. Therefore the individual will be allocated to Cluster 2 (Blue). The positive 
predictive value associated with belonging to cluster 2 is 90%. Therefore if the person is 
allocated to Cluster 2 using the above decision tree there is a 90% chance this allocation is 
correct.                           
Naevi 
Naevi 
Naevi 
Naevi 
Naevi 
Naevi 
Naevus 
Naevus 
Naevus 
Naevus 
45 
 
CHAPTER 4. PHENOTYPE AND GENOTYPE CHARACTERISATION AND ANALYSIS 
IN NAEVUS DISTRIBUTION CLUSTERS 
 
Pigmentation of hair, eye and skin colour in humans are controlled by a large number of 
identified genes. However, polymorphisms in just 15 of these genes have a large effect on 
the variation of pigmentation seen between and within human populations [176]. These 
genotypes are associated with altered activity, or expression, of enzymes and proteins 
involved in melanin level regulation. Multiple single nucleotide polymorphisms (SNPs) in 
these genes have been studied in an effort to establish their association and influence on 
pigmentation and melanoma risk. This has largely been driven by the increasing use of 
genetic testing in association with personalised medicine for patient care and management.  
 
Many genes also contribute to naevus count, other phenotypic traits and melanoma risk. 
The presence of opposing melanoma risk phenotypes are indicative of multiple melanoma 
pathogenesis pathways: darker pigmentation with many naevi and greater propensity for 
naevus proliferation, or pale pigmentation with few naevi and increased susceptibility to 
sunburn and UV damage [63]. Findings from the GEM study also concluded that there was 
no association between pigmentation phenotype characteristics and the number of naevi 
[177]. Given the evidence of diverse pathways for melanoma formation, it was hypothesised 
that there would be no relationships between patterns of naevus distribution and hair and 
eye colour in the BNMS population i.e. clusters would not be associated with hair and eye 
colour.  
 
4.1 Melanoma Status 
Melanoma status was collected in participant reports and confirmed by histopathology 
reports. In the selected individuals from the BNMS, 575 participants had a personal 
melanoma history, 158 had familial melanoma history and 486 controls had no melanoma 
history. Personal melanoma history correlated highly with a high total body naevus count. A 
significant association between melanoma status and the three clusters was observed within 
the study population (P<0.0001). Three clusters were derived from mclust analysis based 
on naevus count at each anatomical site after adjusting the variables for age and sex. 
Cluster 1 participants had a high naevus count (49 ± 34) with naevi predominantly distributed 
on the trunk and lower limbs. Cluster 2 participants had a much lower naevus count (10 ± 
4), with fewer naevi present on the trunk and lower limbs, while Cluster 3 participants had 
the lowest naevus count (4 ± 5) of all three clusters, with naevi, if present, located on the 
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back. Cluster 1 contained the highest proportion of participants with personal melanoma 
history (65.6%), compared to Cluster 2 and Cluster 3, and also recorded the lowest 
proportion of controls (22.2%). Cluster 3 had the highest proportion of controls from all three 
clusters (67.9%), a low proportion of familial melanoma history and the lowest proportion of 
individuals who had a personal history of melanoma (18.7%). Table 11 and Figure 9 
summarise melanoma status according to cluster. Post-hoc analysis revealed all clusters 
were significantly different from each other (P<0.0001).  
 
Table 11: Chi-Square analysis comparing the proportion of each melanoma status within 
three clusters 
 Cluster 1 
(n = 427) 
Cluster 2  
(n = 552) 
Cluster 3 
(n = 246) 
P Value  
Personal Melanoma History (%) 280 (65.6%) 249 (45.1%) 46 (18.7%)  
Familial Melanoma History (%) 51 (11.9%) 76 (13.7%) 31 (12.6%)  
No Melanoma History (%) 95 (22.2%) 224 (40.6%) 167 (67.9%)  
No Data 1 (0.2%) 3 (0.5%) 2 (0.8%)  
Cluster 1: Cluster 2    <0.0001 
Cluster 1: Cluster 3    <0.0001 
Cluster 2: Cluster 3    <0.0001 
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4.2 Hair Colour 
Hair colour phenotypes were recorded on a five point scale: red/auburn, fair/blonde, light 
brown, dark brown and black. Light brown hair was the most common hair colour in the 
population (33.1%), followed by dark brown (31.7%). Red/auburn hair was reported in 11.5% 
of the population. Hair colour was not reported for 1.4% of the study population. Fisher’s 
exact test indicated there was a significant relationship between hair colour and clusters 
(Figure 10, P=0.007). Post-hoc pairwise comparisons indicated that hair colour in Cluster 1 
was statistically different from Cluster 3 (P=0.005). A summary of cluster composition 
according to hair colour can be seen in Table 12 and Figure 10. Cluster 1 has a higher 
percentage of participants with red/auburn hair and a lower percentage of people with dark 
hair compared to both Cluster 2 (P=0.045) and Cluster 3 (P=0.005). There was no significant 
difference between Cluster 2 and Cluster 3 (P=0.354).  
 
 
Figure 9: Melanoma history distribution within three clusters. 46.9% of the study population had 
a personal history of melanoma and 12.9% had a familial melanoma history. Subject melanoma 
history was statistically significant across all 3 clusters (P<0.0001). Cluster 1 contained the 
highest proportion of participants with a personal melanoma history and the lowest proportion of 
participants with no melanoma history. Cluster 1 was statistically different from both Cluster 2 and 
Cluster 3 (P<0.0001). Cluster 3 contained the lowest proportion of participants with personal 
melanoma history and the highest proportion of participants without melanoma history. Cluster 3 
was also statistically different from Cluster 2 (P<0.0001).   
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Table 12: Chi-Square analysis comparing the distribution of hair phenotype across three 
clusters  
 Cluster 1 
N = 427 
Cluster 2 
N = 552 
Cluster 3 
N = 246 
P value  
Red/Auburn 70 (16.4%) 56 (10.1%) 16 (6.5%)  
Fair/Blonde 83 (19.4%) 106 (19.2%) 40 (16.3%)  
Light Brown  136 (31.9%) 181 (32.7%) 88 (35.8%)  
Dark Brown 122 (28.6%) 178 (32.2%) 88 (35.8%)  
Black 15 (3.5%) 28 (5.1%) 13 (5.3%)   
No data 1 (0.2%) 3 (0.5%) 13 (0.4%)  
Cluster 1: Cluster 2    0.045 
Cluster 1: Cluster 3    0.005 
Cluster 2: Cluster 3    0.354 
 
 
 
 
Figure 10: Distributions of hair phenotype. Five phenotypes were noted at time of clinical 
examination. Light brown (33.1%) and dark brown (31.7%) hair colour accounted for the largest 
portion of the study population and within each cluster. Red/auburn hair was reported in 11.5% 
of the population. The relationship between hair colour and clusters was significant (P=0.007) 
(P<0.05). Cluster 1 was statistically different from Cluster 3 (P=0.005). Cluster 1 contained the 
highest proportion of individuals with RHC. 
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4.3 Eye Colour 
Three eye colour categories were assessed in this analysis. Blue/grey was the dominant 
eye colour, accounting for 53.5% of the total population. Blue was also the dominant eye 
colour within each cluster (Table 13). Fischer’s exact test of independence determined that 
a significant relationship between eye colour and clusters was present (P<0.001) and that 
all clusters were statistically different from each other (P<0.001). In Figure 11, an 
incremental increase in brown and green/hazel eyed participants can be observed across 
the clusters. Cluster 3 had a higher proportion of brown eyed and green/hazel eyed 
participants compared to Cluster 1 and 2. Cluster 1 had the highest proportion of blue eyed 
participants compared to Cluster 2 and 3.  Brown eyed participants increased in proportion 
as both naevus count and melanoma incidence decreased, as observed in Cluster 3. 
 
 
Table 13: Chi-Square analysis comparing the distribution of eye colour across three 
clusters  
 Cluster 1 
N = 427 
Cluster 2 
N = 552 
Cluster 3 
N = 246 
P value 
Brown 56 (13.1%) 86 (15.6%) 66 (26.8%)  
Green/Hazel 122 (28.6%) 164 (29.7%) 74 (30.1%)  
Blue/Grey 248 (58.1%) 302 (54.7%) 105 (42.7%)  
No data 1 (0.2%) 0 (0%) 1 (0.4%)  
Cluster 1: Cluster 2    <0.0001 
Cluster 1: Cluster 3    <0.0001 
Cluster 2: Cluster 3    <0.0001 
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4.4 Genotypes 
4.4.1 Melanocortin 1 receptor 
The melanocortin 1 receptor (MC1R) gene has been well described in association with 
increased melanoma risk. Lighter pigmentation phenotypes, such as fair skin, sun-
sensitivity, red hair or light hair colour are not only associated with MC1R but also with 
elevated melanoma risk.  While naevi have not frequently been associated with MC1R 
polymorphism, two recent papers have reported an association between increased naevus 
count in carriers of the R/r MC1R genotype [104, 108], suggesting that certain MC1R 
genotypes have a synergistic influence on naevus count.   
 
4.4.1.1 MC1R genotypes and Cluster association  
Nine alleles of MC1R were assessed (Figure 12) by chi-squared analysis and a strong 
statistical association was observed between clusters and the MC1R genotypes (P<0.0001). 
Pair wise comparisons between clusters showed Cluster 1 was statistically different from 
Cluster 2 and Cluster 3 (P<0.0001). There was no statistical difference between Cluster 2 
and Cluster 3. The proportions of the WT/WT and two MC1R genotypes most highly 
associated with red hair (R/R) or increased nevi count (R/r) (Duffy et al. 2009) were 
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Figure 11: Distributions of eye phenotype across three clusters. Blue/Grey was the dominant 
eye colour within the study population (53.5%) and within each cluster. All three clusters were 
statistically different (P<0.001).     
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assessed for significance. The proportion of participants who had the WT/WT (consensus 
or wild type), R/R or R/r genotypes was compared across the three clusters. The WT/WT 
and R/r genotypes were significantly different (P<0.0001) and there was a trend towards 
significance for the R/R genotype (P=0.060). The R/R variants, common in red hair colour, 
were highest in Cluster 1, mirroring the highest proportion of red hair participants in this 
cluster. R/R frequency decreased progressively from Cluster 1 through to Cluster 3. While 
this decreasing proportion of R/R genotype across clusters did not reach significance 
(P=0.06), it may be worth observing this trend in additional, larger study populations. A 
similar decreasing trend was also observed for MC1R variant R/r across clusters. The 
increased frequency of WT MC1R genotype also reflected hair colour trends observed and 
directly correlated with an increase in proportion of darker hair colours, from Cluster 1 to 
Cluster 3.  These early findings suggest that Cluster 1 pattern of naevus distribution may be 
associated with a predominantly lighter hair pigmentation, while Cluster 3 pattern of naevus 
distribution may be associated with darker hair pigmentation phenotypes. 
 
 
Table 14:  MC1R genotype variant distribution across three clusters. RV = rare variant. 
 Cluster 1 
N = 427 
Cluster 2 
N = 552 
Cluster 3 
N = 246 
P value 
R/WT 90 (21.4%) 114 (21.0%) 54 (22.5%)  
R/r 112 (26.6%) 84 (15.5%) 27 (11.3%)  
R/R 46 (10.9%) 40 (7.4%) 15 (6.3%)  
r/r 30 (7.1%) 50 (9.2%) 16 (6.7%)  
r/WT 95 (22.6%) 125 (23.1%) 60 (25%)  
WT/WT 45 (10.7%) 122 (23.1%) 65 (27.1%)  
R/RV 1 (0.2%) 2 (0.4%) 0 (0%)  
r/RV 0 (0%) 0 (0%) 2 (0.8%)  
WT/RV 2 (0.5%) 2 (0.4%) 1 (0.4%)  
Cluster 1: Cluster 2    <0.0001 
Cluster 1: Cluster 3    <0.0001 
Cluster 2: Cluster 3    0.348 
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4.4.1.2 MC1R genotypes and naevus count 
Investigations into the association between pigmentation genotypes and total naevus count 
have resulted in variable outcomes. To date, MC1R has not been frequently associated with 
naevus count [33, 178]. Carriers of MC1R RHC genotypes are more frequently reported to 
have fewer naevi. The association of MC1R variant alleles with a high naevus count has 
proved to be complex [108]. An unexpected finding of this study was the association 
between an increased naevus count, and increased frequency of MC1R RHC alleles, 
specifically for the R/r genotype. The highest proportion of R/r genotype was observed in 
Cluster 1 participants (50.2%), and decreased in Cluster 2 (37.7%) and Cluster 3 (12.1%). 
This trend was particularly noticeable within Cluster 1, which contained participants with high 
total naevus counts compared to Cluster 2 and Cluster 3. Cluster 1 participants also had the 
highest proportion ‘R’-alleles (R/R, R/r, R/WT) while Cluster 2 and 3 participants were more 
likely to have ‘r’-alleles. This association was also recently described by Duffy et al in an 
Australian population where individuals with red hair had the highest mean total naevus 
count in both control and melanoma cases for participants with R/r genotype, but not R/R 
genotype [108]. A tendency towards an increased naevus count was also reported for R/r 
genotype for naevi  2 mm in a study of naevus and freckling phenotypes in children [104].  
  
Figure 12: MC1R genotypes distribution within three clusters.  A statistical association was 
reported between clusters and MC1R (P<0.0001). Cluster 1 was statistically different from 
Cluster 2 and Cluster 3 (P<0.0001).   
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4.4.1.3 MC1R genotypes and melanoma risk 
The distribution of MC1R genotypes was also associated with participant melanoma history 
in the three clusters. Specifically, melanoma history is strongest in Cluster 1 (Figure 8) and 
R allele is more frequently found in Cluster 1 (Figure 12). The wild type (WT) genotype was 
more frequently found in individuals without a history of melanoma.  This can be observed 
particularly in Cluster 3 participants who have the lowest incidence of melanoma and the 
highest frequency of the WT allele (P<0.0001). Consistently, participants within Cluster 1 
had the highest proportion of R variants, with R/R, R/r and R/WT accounting for 59% of all 
participants. The frequency of the R/r genotype (red) in Cluster 1, which had the highest 
frequency of melanoma, was statistically much higher than in Clusters 2 and 3 (P< 0.0001).  
 
4.4.2 Oculocutaneous Albinism Type II   
Coding and non-coding regions of the Oculocutaneous Albinism Type II (OCA2) locus, 
encoding the melanosomal associated P-protein, are the primary driver for determining 
human eye colour [31, 137, 179-181].  Multiple SNPs of OCA2, span in to the intergenic 
region and encompass the 3’ end upstream gene, HERC2 and are thought to be in linkage 
disequilibrium with its functional elements [133]. Therefore, multiple SNPs of OCA2 were 
assessed (rs16950821, rs4778138, rs1470608, rs7174027, rs7495174 and rs12913832). 
Analysis in PRISM showed a relationship was present between all clusters and specific 
OCA2 SNPs; rs7174027 (P=0.006), rs4779138 (P=0.005) and rs7495174 (P=0.015) 
(Figure 13). Chi-square analysis showed that the proportion of the alternate allele in the four 
OCA2 SNPs evaluated was significantly lower in Cluster 1 as compared to Cluster 3; 
rs7174027 (P= 0.0006), rs4778138 (P=0.006), rs7495174 (P=0.001) and rs12913832 
(P=0.022). Furthermore, the alternate allele for SNP was lower in Cluster 2 as compared to 
Cluster 3 for rs12913832 (P=0.005), rs7174027 (P=0.022) and rs7495174 (P=0.027). These 
results are consistent with the fact that brown eyes were more common in Cluster 3 
compared to the other two clusters (Figure 13). 
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4.4.3 Interferon Regulatory Factor 4 
The relationship between IRF4 rs12203592*C/T genotype and clusters was assessed, given 
its previous association with naevus count (Figure 14) [182, 183]. Fisher’s exact test for 
independence indicated there was a relationship between clusters and IRF4 genotype in 
this population (P=0.007). Post-hoc pairwise comparisons showed that Cluster 1 was 
statistically different from Cluster 3 (P=0.001) and Cluster 2 was statistically different from 
Cluster 3 (P=0.001). Clusters 1 and 2 were more likely to contain participants with a T/T 
genotype than those in Cluster 3. There was no significant difference between Cluster 1 and 
Cluster 2 (P=0.058) (Table 15).  
 
 
 
 
 
 
Figure 13: OCA2 genotypes distribution across three clusters. A. rs7174027 B. rs4778138 C. 
rs7495174  D. rs12913832 **=P<0.05 
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Table 15: Chi-square analysis of IRF4 genotype distribution across three clusters. 
 Cluster 1 
N = 427 
Cluster 2 
N = 552 
Cluster 3 
N = 246 
P value 
C/C 237 (56.4%) 311 (57.5%) 161 (66.8%)  
T/T 36 (8.5%) 40 (7.4%) 5 (2.1%)  
C/T 147 (35%) 190 (35.1%) 75 (31.1%)  
Cluster 1: Cluster 2    0.058 
Cluster 1: Cluster 3    0.001 
Cluster 2: Cluster 3    0.001 
 
 
 
 
4.4.4 Microphthalmia Transcription Factor 
A rare variant in the microphthalmia transcription factor (MITF), resulting in coding changes 
to E318K (rs149617956), has recently been identified as contributing to increased naevus 
count and melanoma risk [30]. Therefore, the role of the MITF 318K variant within this study 
population was assessed. The minor allele frequency (maf) of E318K (rs149617956) is 
0.001326 in a control cohort of 60,000 individual [184]. In the BNMS cohort, no homozygous 
carriers were detected (Figure 15). There were 23 heterozygotes detected in a population 
of 1,125 (maf 0.0102), most of whom had a diagnosis of melanoma (n= 15 participants from 
23). This incidence rate was significantly higher than the control ExAC cohort (P=0.000023) 
Figure 14: IRF4 genotype distribution within three clusters. Cluster 1 was statistically different 
from Cluster 3 (P=0.001) and Cluster 2 was statistically different from Cluster 3 (P=0.001). C/C 
carriers (WT in blue), were equally distributed across all three clusters.  
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[184]. Despite the small number of 23 heterozygotes in the whole study population, there 
was a significantly higher proportion of 318K carriers in the high naevus cohort (Cluster 1) 
compared to the lower naevus count groups, Cluster 2 (P=0.001) and Cluster 3 
(P=0.006).  There was no significant difference between Cluster 2 and Cluster 3 (P=0.451).  
 
 
 
4.4.5 Methylthioadenosine Phosphorylase and Phospholipase A2 Group VI  
Multiple SNPs in methylthioadenosine phosphorylase (MTAP) and Phospholipase A2 
Group VI (PLA2G6) genes were assessed (Figure 16 and 17). Chi-square analysis found 
that there were significant associations between clusters and variants at MTAP rs7023954 
(P=0.0399), rs4636294 (P=0.012) and rs7023329 (P=0.008). For rs7023954, homozygous 
variant was associated with Cluster 1 (Figure 16). Cluster 1 was statistically different from 
Cluster 2 (P=0.005), and Cluster 3 (P=0.015). There was no significance between Cluster 
2 and Cluster 3 (P=0.854). For rs4636294, Cluster 1 had significantly more variant alleles 
than Cluster 2 (P=0.017) and Cluster 3 (P=0.002). There was no significance between 
Cluster 2 and Cluster 3 (P=0.261). For rs7023329, Cluster 1 had significantly more variant 
alleles than Cluster 2 (P=0.027) and Cluster 3 (P=0.001).There was no relationship 
between Cluster 2 and Cluster 3 (P=0.115).  
 
Figure 15: MITF E318K genotype distribution within three clusters. A significant relationship 
between MITF E318K genotype and clusters was observed (P≤0.001). Cluster 1 was significantly 
different from Cluster 2 (P=0.001) and Cluster 3 (P=0.006). 
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A relationship between clusters and rs743465 was also observed (P=0.039), however, 
there was no significant difference between clusters. No relationship was present between 
three SNPs rs147028761, rs10811629 and rs4478653 and clusters. 
 
 
Multiple SNPs in the PLA2G6 loci were assessed (Table 2, Figure 17). Post hoc analysis 
for rs132985 indicated all clusters were significantly different from each other (P<0.0001). 
For rs2284063, Cluster 1 was statistically different from Cluster 3 (P<0.0001) and Cluster 2 
was statistically different from Cluster 3 (P<0.0001). There was no significance between 
remaining PLA2G6 variant alleles in Cluster 1 and Cluster 2 (P=0.079) in this study 
population.     
 
Figure 16: Distributions of MTAP genotypes variants within three clusters A. MTAP rs4636294. 
B. MTAP rs7023954 C. MTAP rs7023329  
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4.4.6 Cyclin-dependent Kinase Inhibitor 2A  
Cyclin-dependent kinase inhibitor 2A (CDKN2A) is a known high penetrance gene strongly 
associated with familial melanoma and naevus count [126, 183].  Therefore, its frequency 
and association with naevus distribution pattern was evaluated in this population (Figure 
18). Chi-squared analysis assessed the relationship between clusters and CDKN2A SNPs. 
Significance was observed for a single SNP (rs21970916 A148T, P=0.04), however the 
relative frequency of this SNP across clusters was not significantly different (Cluster 1 vs 
Cluster 2 P=0.593, Cluster 1 vs Cluster 3 P=0.641, Cluster 2 vs Cluster 3 P=0.388).  
 
Figure 17: PLA2G6 genotypes distribution within three clusters A. PLA2G6 rs132985. 
Significance between clusters and PLA2G6 rs132985 was noted (P<0.0001). All clusters were 
statistically different from each other (P<0.0001). B. PLA2G6 rs2284063. Significance between 
clusters and PLA2G6 rs2284063 was observed. There was a decrease in homozygous genotype 
observed across clusters from left to right. Cluster 1 was statistically different from Cluster 3 
(P<0.0001) and Cluster 2 was statistically different from Cluster 3 (P<0.0001).   
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Figure 18: CDKN2A genotype distribution within three clusters. There was no significant 
difference between CDKN2A variants and clusters.  
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CHAPTER 5: DISCUSSION AND CONCLUSIONS  
 
The study aimed to determine whether naevus distribution patterns could be identified and 
classified for naevi ≥ 5 mm in a cohort comprised of individuals with a personal history of 
melanoma, a family history of melanoma and controls. Three distinct naevus distribution 
pattern groups were identified in the BNMS population using the Gaussian finite mixture 
modelling approach (mclust). These clusters grouped similar individuals, based on their 
naevus count across the body sites (arms, legs, back and chest/abdomen). Cluster 1 
contained individuals with a high total body naevus count, predominantly located on the 
trunk and either the upper or lower limbs. This cluster was strongly associated with a 
personal history of melanoma. The total naevus count was lower in individuals in Cluster 2, 
with more naevi located on the back as opposed to the limbs. Individuals in Cluster 3 had 
minimal naevus counts and were more likely to be controls than to have a melanoma history. 
A highly accurate classification tree was developed to provide a simple clinical tool for 
allocating patients into the three naevus distribution pattern clusters described. Further 
characterisation of these clusters according to phenotypic traits found that Cluster 1 
individuals were more likely to have light or red coloured hair and were less likely to have 
dark coloured eyes, compared to the other two cohorts. Consistently, SNPs in pigmentation 
genes previously associated with naevus count and/or pigmentation i.e. MC1R, MTAP, 
OCA2, MITF and PLA2G6 showed an expected relationship with the respective clusters.  
 
5.1 Naevus Distribution Patterns in this Model 
Although overall total naevus counts in this cohort were lower than previously been reported 
in the literature [54, 62, 91], this is most likely due to the size threshold employed by different 
studies (i.e.  ≥ 5 mm in this study versus ≥ 2 mm in others). There were sex associations 
with naevus count in this study: overall males had a higher number of naevi ≥ 5 mm 
compared to females, as described in previous studies [54, 62, 81, 91]. The back was the 
most common site of naevi for both sexes, which is consistent with previous studies [54, 62, 
91]. Men were found to have a higher naevus count on the back and chest/abdomen region 
in comparison to women [59]. This distribution pattern has been previously described and 
has typically also been associated with a corresponding increase in naevus count in the 
lower limbs in women [54, 91]. Although the proportion of naevi on the legs was higher in 
women, this did not reach statistical significance. This may be reflective of population size 
and/or the cut-off selected for naevus size.  
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Multiple studies have shown that the number of acquired naevi increases in the first two 
decades of life. Naevus counts then stabilise in the third decade, before starting to involute 
in the fourth decade [185-187]. We expected that naevus count would be associated with 
age in this cohort. However, the limited naevus count in Cluster 3 complicated the analysis. 
Individuals in this cluster are predisposed to have fewer naevi, and this may be influenced 
by multiple factors such as genetics and a low propensity for melanocytic proliferation. The 
associations between genotype and clusters would further support this finding. This is 
discussed further below. Again, the ≥ 5 mm cut-off in our study criteria may have affected 
the detection of such an association.   
 
The distribution of naevi in the first two clusters showed some trends: naevi were present in 
higher numbers in all anatomical sites in Cluster 1, while they were predominantly found on 
the back in the Cluster 2. This may be validated with a larger cohort and/or by inclusion of 
smaller naevi (i.e. 2-5 mm). Further research in the future would be valuable to determine 
whether specific patterns of naevus distribution across the body are associated with 
increased melanoma risk. This could be combined with naevus count to accurately stratify 
melanoma risk and then to modify individual surveillance accordingly.  
 
Using three clusters to describe a pattern of naevus distribution can be considered a quick 
and simple method to stratify individuals by utilising known risk traits like naevus number 
and pigmentation phenotype in the clinical setting. The model proposed here is a stepwise 
approach whereby the assessor begins by counting naevi on the back and if it exceeds the 
appointed threshold (≥ 9 naevi of ≥ 5 mm), no further assessment is necessary to classify 
this individual as Cluster 1. In those with naevi counts <9, the number of naevi on the legs 
and arms are counted and individuals are subsequently categorised into all three clusters. 
This stepwise approach accurately allocates individuals to clusters in this study. Further 
replication in additional cohorts would be beneficial in validating this model. These 
populations should include diversity of ancestry, ethnic background and geographical 
locations, and the impact of including smaller naevi in the model should also be explored.  
 
In the future, , the proposed model is appealing as it allows for a quick patient evaluation by 
doctors of all skill and experience levels to predict if an individual is at a low, medium or high 
risk for future melanoma incidence. This model contrasts with currently available risk 
prediction models which are comprised of a wide variety of variables [145, 148, 152, 188]. 
All models utilised naevus counts; however, they vary in naevus counting methods and the 
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naevus sizes included, with models utilising trained nurses and doctors or participant self-
count estimates [148]. These factors are logistically challenging in a clinical setting due to 
time and cost restraints, as well as the experience and training level of the examiner [56, 
90]. When naevi are below 5 mm in size, a degree of subjectivity is introduced as to what 
constitutes a true naevus and what might be otherwise classified as a freckle, a solar lentigo 
or a seborrheic keratosis [189, 190]. This introduces a margin of error and affects the 
accuracy and reproducibility of naevus counts [190].   
 
While the simplicity of this model is clinically appealing for triage purposes and the clusters 
showed correlation with personal melanoma history, the proposed model here is not yet 
validated as a risk prediction model for melanoma at this stage. Further studies will be 
required to determine if this can be used as a melanoma predictive tool after naevus 
distribution patterns along with the proposed classification tree model are validated in 
additional populations. Other proposed melanoma risk prediction models take into account 
a wide variety of factors including age, sex, and multiple phenotypic factors (as reviewed by 
Usher et al [148]). Furthermore, recent models have also introduced genotypes as predictive 
variables [17]. The sensitivity and specificity of these models in predicting melanoma risk is 
high but they can be time consuming to administer, and require a high level of skill and/or 
additional tests. Importantly, the majority of studies and models have yet to be validated in 
additional cohorts and require calibration to be population specific [145, 148]. Further 
research is needed to determine whether the cluster model presented here can be used to 
not only predict pattern of naevus distribution but also predict melanoma risk.  
  
As summarised in the literature review, population screening is currently not recommended, 
due to lack of evidence regarding cost effectiveness and marginal improvements in detection 
rates, as compared to opportunistic screening. However, regular surveillance in high risk 
populations has been shown to improve early detection [140]. In such cohorts, the 
documentation of naevus count and size is critical. This is most accurately performed with 
the aid of imaging technologies. Current early detection methods include clinician 
examination and dermoscopy, patient skin self-examination, and 2D total body photography 
[191-193]. With the continuing surge in technology development, total body photography 
has recently evolved to 3D total body photography, with fully rotational, 360 degree avatar 
images of patients now available for use as an aid in the clinical setting [191]. The availability 
of more advanced high-resolution imaging technologies has opened up more opportunities 
for development of new classification and risk prediction models, which can be further aided 
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by artificial intelligence. The rapid, objective documentation of all skin lesions, including 
naevi [191], is appealing for all risk prediction models but also for the model presented here. 
If the model algorithm were included in the software, a 2D or 3D scan could instantly 
document number, size and pattern of distribution and classify individuals to the respective 
clusters. The incorporation of AI into dermatological image evaluation is a promising area. 
 
In a recent landmark study by Esteva et al, artificial intelligence was used to demonstrate 
the accurate classification of melanoma and keratinocyte skin cancers by utilising deep 
convolutional neural networks (CCN), trained directly from images. The classification tree 
accuracy was equivalent to that of a trained dermatologist [194]. Given that the classification 
of melanoma and keratinocyte cancers can be achieved based on images alone, the 
identification of naevi and pattern of naevus distribution from images is also a plausible 
concept. In the future, total body photography and the integration of artificial intelligence and 
machine learning systems (i.e. Vectra 3D Imaging) will become a more common part of 
standard patient care [195]. Using artificial intelligence and deep learning, pattern of naevus 
distribution trends could be identified, classified and described in any given population, and 
streamline the process of naevus distribution pattern model development. Individual 
phenotypic traits can also be collected, including hair, eye and skin colour, and level and 
location of photo-damage on the skin at the time of imaging. If future investigations can 
demonstrate a significant correlation between pattern of naevus distribution and melanoma 
risk, an individual’s melanoma risk status and the appropriate decisions regarding clinical 
management and surveillance could also be aided with such technology. 
 
Based on clinical observation, naevus distribution patterns were anticipated to be visually 
discernible in our study population. It was predicted that naevus pattern would feature 
pattern combinations such as naevus distribution to the trunk and upper limbs, trunk and 
lower limbs, trunk, upper limbs and lower limbs, or upper limbs only. However, such defined 
distribution patterns as these were not clearly recognisable in this study population. This 
was most likely due to the relatively low number of participants allocated to each cluster and 
that only naevi ≥ 5 mm were considered for analysis. If the sample population within each 
cluster was larger and included naevi ≥ 2 mm, these distribution patterns may become more 
discernible.  
 
Multiple anatomical sites and naevus cut-off values have been proposed in the literature to 
predict total naevus count and melanoma risk from specific anatomical sites. Echeverria et 
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al proposed cut-off values for naevus counts on the right arm of 6, 8 and 11 to predict total 
naevus counts of 25, 50 or 100 for common naevi [54]. Gandini et al, Quereux et al and 
Argenziano et al suggest that 20 naevi on the arm is associated with an increased melanoma 
risk, reporting an increase in naevus count on both arms was associated with a higher total 
naevus count [57, 90, 93]. The cut-off values for upper limb naevi proposed in this study 
were lower than what is currently reported in the literature. Once again, this is most likely 
due the fact we considered naevi ≥ 5 mm in size and not ≥ 2 mm, the more frequently cited 
threshold in the literature. Despite this, our model still showed that if participants had more 
than 7 naevi ≥ 5 mm on the upper limbs, they were likely to have a total naevus count of ≥ 
50 naevi ≥ 5 mm. 
 
Summary statistics alone are not enough to assess an individual in the clinical setting, as 
presently the overall pattern of naevus distribution is still not well-defined or clear cut. A 
classification tree serves as a clinical flow chart that can be used to define and allocate an 
individual into a specific cluster. The classification tree proposed indicates that the back, 
arms and legs are the most important sites to review when determining naevus distribution 
pattern, when total body naevus count is excluded as a predictor. A high level of sensitivity 
and specificity are crucial when developing a classification tool [148, 155]. The sensitivity 
for the naevus distribution pattern model proposed here ranged from 85% to 90% from 
Cluster 1 through to Cluster 3. Specificity ranged from 88% to 100%. Overall accuracy was 
high at 88%. The proposed classification tree model, while still requiring external validation, 
would be simple and quick to implement in a clinical setting, and would not necessarily 
require physician input. In the future, recognition algorithms for naevus distribution patterns 
may also reduce the need for physician input. Further models could include other known 
melanoma risk factors including phenotype and genotype information. These could be 
including in the development of the initial clusters, or incorporated into the classification tree 
for clinical use. 
 
The concept of assessing naevus distribution pattern in this manner adds novel insight to 
the clinical method with which we visualise and discuss the anatomical distribution of naevi. 
In comparison to studies to date, which consider naevus number at specific body sites 
individually, this approach takes into account the correlation between numbers of naevi by 
body site across the body as a whole. While naevus distribution patterns have been 
discussed in the literature, reports have commented largely on naevus distribution pattern 
in children and less so in adult populations [52, 76, 78, 80]. Distribution studies in children 
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have frequently reported findings as naevus count or as naevus density to assess and 
comment on pattern of naevus distribution [53, 76]; however, when performing visual 
assessment, assessing density (based on surface area) can be misleading compared to 
naevus count and lead to over or underestimation of the number of naevi at a given site. 
Parallel studies assessed the number of naevi or naevus density, but focus on each 
anatomical site independently [59, 77].   
 
It is possible that there are sub-populations within Cluster 1 which were not detected due to 
an insufficient sample size and/or our selection criteria e.g. naevus size cut-off. A visual 
examination of the principal component analysis bi-plot shows that there may be sub-
populations within Cluster 1. This proposal is supported by the anatomical site correlations 
identified in this analysis. A potential source of sub-populations could be sex specific naevus 
distribution pattern by body site. As variables were adjusted for sex, the corresponding body 
site distribution should be neutralised in the clustering process. However, further analyses 
in a larger cohort should consider labelling each cluster point for males and females 
following the cluster allocation process to determine if sex still has a residual effect on 
distribution. However, sun-exposure may be a confounder here as men and women have 
differing levels and patterns of sun exposure for individual body sites [196, 197]. Therefore, 
the sub-clusters which appear to be sex related, may actually correspond with sun-exposure 
and photo-damage. Additional analyses to tease apart the relative contribution of both sex 
and sun exposure were beyond the scope of this thesis, due to time and possibly cohort size 
restrictions.  
 
Here, an unsupervised clustering approach was applied, to observe the natural structure of 
the data set and naevus distribution pattern. Given the overlapping patterns of naevus 
distribution observed in Cluster 1, the usefulness of this current model may be limited in a 
clinical scenario. Modification to the method of clustering may be required in additional 
research which considers supervised clustering. Supervised clustering relies on user input 
to manually adjust a cluster algorithm to predefine cluster outcomes based on already known 
parameters [198]. It would be interesting to test whether inputting the same naevus counts 
in predefined cluster parameters would produce clusters made of different individuals, and 
result in different proportions of genotypes and phenotypes. 
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5.2 Genotype and Phenotype associations 
Melanoma risk is greatest in individuals with a high naevus count, fair complexion, light hair 
and eye colour, a propensity to sunburn, and familial melanoma history [199]. Numerous 
genes have been identified through their association with pigmentation phenotypes and 
melanoma incidence, naevogenesis and naevus count. Here, the association between 
pattern of naevus distribution as defined by the clusters, pigmentation phenotypes and an 
array of genotypes was explored.  
Many studies, including ours, have reported a strong correlation between high naevus count 
and increased melanoma incidence [51, 52, 57, 80]. Specifically Cluster 1, which was 
characterised by a higher naevus count, also had the highest proportion of participants with 
a personal melanoma history.  The frequency of personal melanoma history decreased with 
subsequent clusters with the number of participants with no melanoma history increasing in 
Cluster 2 and Cluster 3. Familial melanoma history was relatively similar across Cluster 1, 
2 and 3. 
Strong associations were observed between genotypes and some phenotypic traits, e.g. 
eye colour, hair colour and cluster associated naevus distribution pattern. Genotypes which 
also demonstrated potential correlation to naevus distribution pattern within clusters 
included MC1R, OCA2, MTAP, PLA2G6 and MITF. Strong association between IRF4 and 
clusters could not be clearly determined. Although these early findings suggest there is 
some correlation between cluster associated pattern of naevus distribution, phenotype and 
genotype, more research in larger and different study populations will be needed to assess 
this further and to determine whether the observations made here are reproducible and 
applicable for identification and management of higher risk individuals in the clinical setting.  
 
Eye colour is a phenotypic trait that can be easily assessed in the clinic. It was hypothesised 
that eye colour was not associated with naevus distribution clusters. Brown eye colour was 
more frequently observed in individuals with fewer naevi in this study population (i.e. Cluster 
2 and Cluster 3). This increase in the proportion of darker eye colour was also associated 
with an increase in the proportion of darker hair colours. These observations were in 
agreement with previous studies [104] and complemented our observations regarding hair 
colour expression within clusters. Epidemiology studies in adults have reported blue, green 
or grey coloured eyes to be consistently associated with increased development of 
melanoma [27, 32]. In children, reports of higher naevus counts and eye colour were 
associated with blue, hazel or green eyed children in comparison with children with brown 
eyes [76] [83, 104]. As all clusters were statistically different from each other, it was 
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proposed that brown eye colour has a greater association with Cluster 3 type pattern of 
naevus distribution as opposed to Cluster 1 and 2, which are more likely to contain a higher 
proportion of light eyed participants with higher total naevus counts. However, as the 
majority of individuals in all three clusters had light coloured eyes, genotypes associated 
with eye colour warranted investigation.  
 
Blue-brown eye colour is thought to be modulated predominantly by a single SNP 
rs12913832*T/C located in the intron of HERC2 which modulates expression of OCA2, [104, 
200][31, 33, 201, 202]. This SNP is associated with blue eye colour (rs12913832*C) at an 
approximate frequency of 69% in Caucasian populations and 31% of brown eyed 
Caucasians (rs12913832*T) [30, 137]. Previous reports have supported strong associations 
of blue-brown eye colour and rs12913832, and these findings were also observed in this 
study. An association was observed between clusters and genotype distribution of OCA2 
SNP rs12913832, which was greatest in Cluster 1 (high proportion of blue eyed participants). 
Furthermore, the alternate allele frequency for all OCA2 SNPs evaluated (rs7174027, 
rs4778138, rs7495174 and rs1291382) was significantly higher in Cluster 1, compared to 
Cluster 3. In two cases (rs4778138 and rs7495174), it was also higher in Cluster 1 than 
Cluster 2. These findings demonstrate the discriminatory value of OCA2 genotypes between 
these clusters. The association between genotypes and clusters is much clearer than those 
seen with eye colour alone, due to our study population predominately having blue eye 
colour. Eye colour is a useful phenotype in predicting melanoma risk; however, it is reported 
in only few prediction models due to the known association between hair, eye and skin colour 
and freckling [27, 148]. The findings here suggested that eye colour is only weakly 
associated with pattern of naevus distribution observed within clusters and OCA2 genotype 
may be more strongly associated with these clusters. 
 
Hair colour is one of the most identifiable phenotypic traits. While the association of hair 
colour with melanoma risk differs across studies, many have indicated that individuals with 
light coloured hair such as red, blonde and light brown have significantly higher risk of 
melanoma than individuals with darker hair [27, 113]. We hypothesised that hair colour 
would not be associated with cluster naevus distribution pattern. However, we observed that 
Cluster 1 contained the highest percentage of red, blonde and light brown participants and 
had a higher incidence of melanoma, while Cluster 3 contained a higher percentage of 
participants with darker hair colours and had fewer participants with a personal melanoma 
history. These findings suggested that lighter hair colour phenotypes tended to be more 
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frequently associated with a Cluster 1 type naevus distribution pattern, and that darker hair 
phenotypes were associated with a Cluster 3 type naevus distribution pattern.  
 
Variants of MC1R, known as ‘R’-alleles, are strongly associated with increased melanoma 
risk, along with red hair, fair skin and increased propensity to burn [203]. An increase in 
MC1R ‘R’-alleles in Cluster 1 was mirrored by the increase in number of individuals with red 
hair colour. The increased expression of ‘r’ and wild type MC1R alleles, correlating with 
increased participants with dark brown and black hair, was also observed in Clusters 2 and 
3. These findings supported current literature. Hair colour is a valuable trait to consider in 
association with melanoma risk [27] and may be a predictive variable for MC1R status in the 
clinical setting [148, 204]. A relationship between cluster associated pattern of naevus 
distribution, hair colour and MC1R genotype may be present.   
 
Recently, a large study which included this population, found that naevus count was also 
associated with some MC1R genotypes [108]. Unsurprisingly, similar associations were 
observed in this study, where high naevus counts in Cluster 1 were also observed with 
higher frequencies of R/r genotype in comparison to Cluster 2 and 3, which had reduced 
naevus counts and reduced R/r expression. The frequency of the ‘R’-alleles was highest in 
Cluster 1 with 59% of individuals carrying at least one copy of this allele. Cluster 1 also 
contained the highest number of individuals with a personal melanoma history, though the 
association between genotype and melanoma history was not the focus of this study. It has 
been previously shown that the ‘R’-alleles are associated with melanoma risk [205] [206] 
[207], though the association between R/R and naevi count is not as striking [108].   
 
The genotype for the rs12203592 SNP in IRF4 has been previously shown to be strongly 
associated with naevus count [112]. Interestingly, the association correlates with age [112, 
114, 183]. The T/T genotype in children is strongly associated with a higher naevus count 
[183], while the C/C genotype is associated with a higher naevus count in adults [112]. 
Therefore, given that we are studying an adult population, we hypothesised that the 
proportion of C/C carriers would be higher in the high naevi cluster (Cluster 1), compared to 
the low naevus count cluster (Cluster 3). Interestingly, we did not observe this. On the 
contrary, the frequency of T/T genotype was increased in the higher naevus count cluster 
compared to the lower naevus count clusters. This may be an artefact of the corrections 
which were performed on the population to begin with (age adjustment). This was 
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necessary, given the cross-sectional nature of ascertainment. If this were a longitudinal 
study which had spanned from childhood to adulthood, it would have been worthwhile to 
separate the populations according to naevus count for each life stage to observe the 
influence of age-associated C/C and T/T genotypes in naevus evolution. 
 
The IRF4 variant rs12203592*C/T SNP is also strongly associated with darker hair colour 
and lighter eye colour, in addition to naevus counts [30, 113, 114]. It was hypothesised that 
Cluster 1 (high count) would be associated with light eye colour and dark hair colour. In this 
cohort, Cluster 1 did show an association with light eye colour (see Figure 10); however, it 
was associated with lighter hair colour. This is not unexpected given the heterogeneity of 
hair colour and the fact that we did not control for MC1R genotype, which is one of the 
strongest predictors of light hair colour.  
 
In a study by Gibbs et al, participants who were C/C genotype carriers developed melanoma 
at an earlier age (~ 45 years), while participants with the T/T genotype showed melanoma 
onset at a later age (~ 75 years). Participants with the C/T genotype had a bimodal age 
distribution with peaks at age 50 and 70 years, which likely indicated the presence of an 
additional genotype modifier for the C/T genotype [114]. This effect on personal melanoma 
history was not observed in this study. This was due to the relatively equal distribution of 
C/C carriers across all clusters. The highest proportion of C/C carriers was observed in 
Cluster 3, which had the lowest incidence of melanoma, the lowest total naevus counts and 
the youngest age cohort. Therefore, as the mean age in Cluster 3 (38.4 ± 14 years) is lower 
than the mean age of melanoma onset in C/C carriers proposed by Gibbs et al, it is possible 
that a number of this cohort (Cluster 3) have yet to develop melanoma.  As there was a 
relatively equal distribution of C/C carriers across all clusters, direct associations to 
melanoma risk were less clear. In this study, the direct interpretation of IRF4 was difficult. 
As variables were adjusted by age, a clear conclusion between IRF4 genotype and influence 
on naevus count, melanoma incidence and association to pattern of naevus distribution 
could not be made. 
 
Carriers of the MITF E318K mutation have a two- to five-fold increase in melanoma 
development [129]. Despite their small number in the BNMS population, heterozygous 
carriers of the E318K genotype were predominantly present in Cluster 1, which was also 
associated with previous melanoma history and higher naevus counts. This genotype is 
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known to be associated with an increased risk of developing melanoma [129, 208] and an 
increased naevus count [163].These associations are highly consistent with the literature 
[30, 101, 127]. However, given the relatively small number of heterozygotes (n=23), it was 
not possible to explore the relationship between the genotype and naevus distribution 
pattern in this study.  
 
Genetic interactions between MTAP and PLA2G6 have previously been reported to 
influence naevus count [22, 116, 117]. Here, a progressive decrease in naevus count from 
Cluster 1 to Cluster 3 was observed. This decrease in naevus count corresponded with a 
decrease in participants who were homozygous for MTAP (SNPs rs7023954, rs7023329 
and rs4636294) in the study cohort. A similar decrease in PLA2G6 homozygous participants 
(SNPs rs132985 and rs2284063) with decreasing naevus count was also observed in 
Cluster 2 and 3 (when compared to Cluster 1).  
 
MTAP SNPs rs7023329, rs7023954 and rs4636294 showed strong correlations to cluster 
associated naevus pattern, with A/A homozygous individuals having significantly higher 
naevus counts than A/G or G/G individuals [117, 118].  However, previous reports vary on 
the directionality of the effect of MTAP on naevus count. A UK study found the reverse 
relationship between naevus count and MTAP, with G/G individuals having the higher 
naevus counts. This could potentially be due to the fact that only one SNP, rs7023329, was 
considered, rather than the full haplotype considered in our study [117].  
 
MTAP and PLA2G6 have also been cited as contributing to melanoma risk [119, 209]. Our 
study findings suggested an increase in melanoma incidence with increased proportions of 
homozygous carriers of the A alleles of MTAP rs7023954, rs7023329 and rs4636294. 
Similar findings were also reported by Maccioni et al, who found the greatest increased risk 
for melanoma was for homozygotes of the A allele, for rs4636294 in a Spanish population 
[209]; and similar findings were reported in studies assessing individuals for susceptibility to 
melanoma and number of naevi in melanoma-prone families with and without CDKN2A 
mutations [116, 118, 126]. 
 
The haplotype surrounding PLA2G6 includes intronic SNPs rs11570734*A/G, 
rs2284063*A/G, rs60012027*A/G and rs4384G/C. This haplotype, along with SNP 
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rs132985, has been associated with increased melanoma risk [30, 116]. Our study findings 
showed an increase in melanoma occurrence in participants who were PLA2G6 rs13985 
and rs2284063 homozygous carriers. Previous studies have found that, in combination with 
other pigmentation and naevus associated genotypes including MTAP rs4636294*A and 
IRF4 rs12203592*T, PLA2G6 variants synergistically increase naevus count and melanoma 
risk [116, 210]. From the observations made here, we can propose that three SNPs for 
MTAP and two SNPs from PLA2G6 were associated with cluster pattern of naevus 
distribution. Specifically clusters with higher naevus counts had higher proportions of these 
SNPs in this study population, contradicting the predicted hypothesis.  
 
CDKN2A gene variants are very rare, given the small gene size and its limited tolerance for 
mutation [184] and is only reported in approximately 1 to 2% of all melanoma cases 
[211].Therefore, a low carrier frequency was anticipated in this population. The findings of 
this study did not reach statistical significance, given the rarity of this mutation and the limited 
sample size. It would be worthwhile to observe this genotype in additional study populations. 
Given the low incidence of this mutation in the population overall, the proposed hypothesis 
was that a correlation between CNKN2A genotype and cluster associated naevus 
distribution pattern would not be identified. This hypothesis was consistent with literature, 
which shows that it is not CDKN2A variants which correlate with naevi, but rather other 
genotype variants such as MC1R and MITF which are co-inherited with CDKN2A variants 
and modify phenotype [126]. 
 
Overall, the associations reported here between genotype and cluster associated pattern of 
naevus distribution supported the proposed dual pathways to melanoma development, 
where participants have multiple elements from each risk type [63] [105, 106, 108, 212]. We 
can also observe in our cohort how these pigmentation-associated candidate genes 
influence phenotype and melanoma risk and their association to cluster. However, these 
results also further reinforce the well documented fact that the number of naevi is one of the 
most important phenotypic indicators for melanoma risk [57, 213]. 
 
5.3 Strengths and Limitations 
The key strength of this study was the large study population which increased the statistical 
power of the results for the development of a robust classification tree model, along with a 
comprehensive documentation of participants’ total body images, phenotypic and genotypic 
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traits. There were several limitations in this study. Firstly, the study population was slightly 
enriched with melanoma patients, referred from dermatology clinics and hospital settings. 
Secondly, convenience sampling was used when recruiting controls. These individuals had 
either previously consented to naevi related studies, or were the relatives of case 
participants, thereby, introducing a potential source of bias. External validation of this model 
in additional case and control populations is therefore required. A third limitation was the 
exclusion of skin colour and skin type in the cluster analysis, even though this is a well-
known phenotypic risk factor for melanoma. This variable was excluded on the basis that 
the study population was predominantly of European decent, with the majority of participants 
classified as Fitzpatrick Type I or II. However, further investigations into naevus distribution 
patterns and additional classification models should incorporate and explore the association 
between skin colour and naevus distribution pattern in different populations and ethnicities 
and the relationship and influence of skin colour with genotype. This may be done by 
assessing skin colour using spectrophotometry for a less subjective measure [214]. As the 
cluster associated pattern of naevus distribution described here was modelled on a 
population with limited skin phototypes, additional validation in populations with wider 
variation of skin phototypes and geographical origin will be necessary to observe if study 
outcomes are altered. The level of solar damage and sunburn history were also not 
considered variables in clustering and the current classification tree model. This was due to 
the requirement of a photo-damage grading scale and the potential for subjective bias in 
determining level of photo-damage [215]. As UV exposure stimulates naevogenesis and 
melanocyte proliferation, future research should incorporate and investigate this risk factor 
and the association between UV photo-damage skin, location and surface area of photo-
damage skin and naevus distribution pattern.  
 
In reviewing the literature, it was observed that the selected cut-off value for naevus size 
varied across studies, with a large portion of studies focusing on naevus size ≥ 2 mm [54, 
79, 91, 216, 217]. While this observation was noted when commencing initial study design, 
it was decided that modelling should be based solely on naevi ≥ 5 mm. It is far easier to 
identify a ‘true’ naevus in this size range due to clearer dermoscopic and clinical features 
[190]. It was also thought that this would increase the accuracy and reproducibility of study 
results. The inclusion of smaller sized naevi compromises diagnostic accuracy as 
distinguishing a < 5 mm naevus from a solar lentigo or superficial seborrhoeic keratosis 
particularly on sun-damaged skin is not straightforward, and non-naevus lesions might be 
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mistakenly included in the count [189, 190]. An additional potential limiting factor of many 
published studies is the variation in naevus count method and the skill level of the individual 
conducting the count. Study reports range from self-reported counts, to trained research 
assistants, nurses and dermatologists. The significant variation in the level of training and 
skill, of those conducting naevus count can also influence accuracy and reproducibility of 
the results when considering naevi smaller than < 5 mm [57, 189, 218]. 
 
It can be argued that observing the distribution pattern of naevi ≥ 5 mm results in identifying 
and characterising naevus distribution pattern present in only a select portion of the 
population, and may be more specific to individuals with dysplastic naevus syndrome or 
atypical mole syndrome. Individuals allocated to Cluster 2 or Cluster 3, which have few naevi 
≥ 5 mm in comparison to Cluster 1, may in fact have a high naevus count for naevi ≥ 2 mm, 
which is not captured using the current modelling approach. This would be another avenue 
of research for the future, assuming that naevi of this size range could be accurately 
classified. It would be interesting to ascertain whether naevus counts from ≥ 2 mm and ≥ 5 
mm followed a similar pattern of naevus distribution. Given that individuals allocated to 
Cluster 1 had a higher incidence of melanoma history in comparison to Cluster 2 and 3 
participants, and strong genetic associations were observed between Cluster 1 and genes 
such as MC1R, MTAP and PLA2G6, it would be interesting to see if these associations 
differed when analysis included naevi ≥ 2 mm. 
 
Presently, at least 15 major genes are associated with pigmentation phenotype, with 
additional naevi and melanoma risk genes also identified [22], of which 5 were investigated 
in this study. With ongoing GWAS investigations and the increased use of personalised 
medicine in clinical practice, our knowledge of genotypes which influence melanoma, naevi 
and pigmentation will continue to expand. Future research will further explore these 
associations through melanoma risk models and their ultimate influence on the clinical 
management of patients and disease outcomes. 
 
The classification tree model presented here relies on naevus count alone in assigning 
individuals to clusters. It is reasonable to assume that the inclusion of additional risk factors 
such as hair and eye colour might increase the sensitivity and specificity of this 
categorization. However, parallel work in this research centre has shown that the inclusion 
of hair and eye colour did not enhance the accuracy of cluster stratification (unpublished 
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data). This may be due to the low specificity of these traits in predicting naevus count [219]. 
The methodology employed in this analysis relied on an unsupervised clustering approach. 
It may be worth investigating whether other methods, such as supervised clustering 
approach, or incorporates expert clustering of study participants or 3-D avatars, which may 
provide better defined clusters that would be more applicable in a clinical setting. 
 
Numerous common genomic variants associated with increased susceptibility to melanoma 
have been identified through genome-wide association studies, however, knowledge on the 
utility of these variants to risk prediction models for melanoma is limited [204]. Currently, 
studies have shown variable outcomes when genetic markers are incorporated into 
melanoma prediction models together with traditional risk factors [17, 119, 220]. 
Pigmentation and melanoma genes such as MC1R, which have been shown to be 
associated with melanoma risk independent of phenotype, have also been proposed and 
considered for inclusion in risk prediction models [105, 204, 221, 222]. Preliminary findings 
from this study showed genotypes such as OCA2, MITF, PLA2G6, MC1R and MTAP had 
potential affiliation with cluster associated naevus distribution pattern, and that their 
phenotypic expression was affiliated with melanoma occurrence, which may be worth 
incorporating into the proposed classification tree model. The incorporation of genotype into 
a prediction cluster model with naevus distribution pattern is concurrently being investigated 
by other researchers within our group. At this stage, genotype was not considered for 
incorporation into a clinical classification tree model, as it could not be readily assessed in 
a clinical setting. The accuracy of using genotype in determining risk through a risk 
prediction model in the clinical setting is also not yet confirmed [222] [119, 220].  
 
In an ideal scenario, a risk prediction algorithm would include all known phenotypic risk traits, 
genotypic analyses and naevus distribution pattern to offer optimal sensitivity and specificity. 
The complexity of incorporating genotype into a predictive model is challenging. Aside from 
the logistical considerations of sample collection, test standardisation and appropriate SNP 
selection, the computational considerations of incorporating genetic information into risk 
prediction models is significant. The resulting benefit to risk stratification would have to be 
clinically feasible, cost-effective, and result in enhanced patient management plans.  
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5.4 Conclusions 
Although total naevus counts and naevus counts in specific anatomical sites have been well 
explored as risk factors, naevus distribution pattern has not been similarly considered. This 
is surprising given the wealth of studies assessing anatomical distribution of acquired 
melanocytic naevi in both children and adults. The concept of applying naevus distribution 
pattern to aid in the identification of at-risk individuals for surveillance is novel.  
 
This study has identified three clusters which differ by naevus distribution patterns.  Cluster 
1 contained participants with a high total body naevus count, where naevi were 
predominantly centralised to the trunk and either the upper or lower limbs. Cluster 2 
constituted participants with lower relative naevus counts at each anatomical site in 
comparison to Cluster 1. Naevi in this cluster were more likely to be located to the trunk and 
extremities. Cluster 3 contained participants with the lowest naevus counts from all three 
groups, with the rare naevi present likely to be located to the back.  An early classification 
tree model was also proposed, which was surmised from a cohort in Brisbane, Australia. 
This classification tree would be a quick and easy tool to administer in the clinical setting. In 
theory, it enables a rapid stratification assessment of an individual, through a simple visual 
overview of the number of naevi and pattern of naevus distribution across each anatomical 
site. Few studies have discussed the interaction between pattern of naevus distribution and 
total naevus number in relation to phenotypic and genotypic features [17, 27, 69, 223]. This 
study is one of the few where the combination of phenotype and genotype are explored in 
relation to naevus distribution pattern for naevi ≥ 5 mm, in an adult population of European 
ancestry. From this study, hair and eye colour and were shown to be useful phenotypic traits, 
but not when incorporated into the classification tree model. Significant associations 
between cluster associated pattern of naevus distribution and genotype variants in MC1R, 
OCA2, MTAP and PLA2G6 were also observed, though these were also not incorporated 
into the model, as this information is not readily available in the clinical setting. The 
classification tree, which takes into account the variation of naevus number on the various 
body sites, is a novel concept of approach and has the potential to provide rapid identification 
of at-risk individuals in the clinical context. 
 
With the continuing development of imaging technology in dermatology, artificial intelligence 
will contribute significantly to future patient management, risk prediction modelling and 
surveillance programs. The incorporation of the presented risk stratification model into a 
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computationally-aided imaging technology will allow that individuals be instantaneously 
categorised once imaging is performed.  
 
This study is yet to determine whether there is a definitive association between pattern of 
naevus distribution and melanoma risk. Further research is needed to determine whether 
defined naevus distribution patterns differ when smaller naevi are incorporated. Finally, 
replication studies are needed to validate these findings in additional populations to 
determine the possible merit of this tool in a clinical setting. If validated, this research may 
be beneficial to specialist and general clinicians wishing to rapidly and accurately classify 
their patients into naevus cluster types.  
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